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Objective: Attention Bias Modification Training (ABMT) for anxiety aims to train 
attention away from threatening stimuli and toward neutral stimuli. Although ABMT 
shows promising anxiety reduction effects in children and adolescents, no study has 
examined its influence on neural indicators of attention measured using event-related 
potentials (ERPs) in children or adolescents (i.e., youths). The present study examined 
the influence of ABMT on the P1, N170, P2 and P3 ERP components during completion 
of the emotional faces dot probe task in youths with anxiety disorders who failed to 
respond to cognitive behavioral therapy. Method: Thirty youths (M age = 11.97, SD = 
2.89) with primary DSM-IV-TR anxiety disorders completed the dot probe task while 
undergoing electroencephalogram (EEG) to obtain ERPs before, immediately after, and 
eight weeks after eight sessions of either ABMT (n = 14) or a control task regimen (CT), 
(n = 16). Results: At post-treatment, statistically significant effects were found for P1 and 
P3 mean amplitudes: P1 was significantly higher during trials showing neutral-neutral 
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(NN) face pairs in the ABMT arm than in the CT arm; P3 was significantly higher during 
trials showing NN face pairs than during trials showing neutral-threat (NT) face pairs in 
the ABMT arm, but not the CT arm. At eight-week follow-up, participants in both arms 
showed significantly higher (more negative) N170 responses for NN trials than for NT 
trials. Conclusions: Attention Bias Modification Treatment led to increases in neural 
processing of neutral stimuli in early and late stage attentional processing, as measured 
by the P1 and P3 components, respectively. These components during the dot probe task 
are promising neural markers of ABMT’s effects on attentional processing in youth with 
anxiety disorders.  
Keywords: Attention bias, Attention Bias Modification Treatment (ABMT), Event-
related potential, anxiety, youth. Abbreviations: DSM-IV-TR: Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition, Text Revision; ADIS for DSM-IV: C/P: 
Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions; 
SCARED-C/P: Screen for Child Anxiety & Related Disorders, Child & Parent Versions; 
PARS: Pediatric Anxiety Rating Scale; ERPs: event-related potentials; EEG: 
electroencephalogram. 
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I. RESEARCH STATEMENT  
 I am pursuing a program of developmental translational neuroscience, focused on 
a) the identification of behavioral and neural markers of attentional processes involved in 
the development and maintenance of anxiety in children and adolescents, and b) the 
evaluation of treatments designed to alter the pathophysiology of attentional processes 
related to anxiety, including Attention Bias Modification Training (ABMT). As such, my 
training integrates behavioral and neuroscientific methodologies to identify contributing 
attentional networks and how and for whom neurally-informed treatments are most 
helpful.   
Gaps in Understanding Attention and Anxiety 
Anxiety disorders are among the most prevalent psychiatric disorders in children 
and adolescents (hereon referred to as “youth”). Up to 50% of youth continue to meet 
criteria for anxiety disorders and continue to experience emotional distress and 
impairment after a full course of cognitive-behavioral therapy (CBT), the leading 
evidence-based psychosocial treatment for anxiety disorders. These youth continue to 
suffer emotional distress and impairment associated with anxiety disorders, including 
frustration by perceived failure to respond to a “treatment that works,” and pose a 
financial burden on the health care system. These findings highlight the need for novel 
treatments informed by the neural underpinnings of anxiety in youth. 
There is substantial evidence of threat-related attention bias in anxiety from 
behavioral research, including research on youth with anxiety disorders. However, 
behavioral paradigms are unable to provide precise temporal information about where in 
the stream of attentional processing perturbations exist for anxious youth. Further, 
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although the translational treatment implication of attention bias to threat, ABMT, shows 
promising anxiety reduction effects, the influence of ABMT on neural activity related to 
attention bias is not well characterized. That is, whether and how ABMT produces 
changes in underlying neural processes remains unknown.  
To identify the neural correlates of attention processes, including threat-related 
attention bias, researchers have examined event-related potentials (ERPs) time-locked to 
the onset of the visual stimuli presented in a dot probe task. With respect to threat-related 
attention, researchers have focused on ERP components that correspond to early stage 
processing associated with attention orienting (P1) or face recognition (N170) and 
components that correspond to later, more complex attention processes such as stimulus 
evaluation (P2) and response inhibition (P3). As elaborated in my dissertation studies, 
past research has provided evidence supporting the potential value of exploring such ERP 
components to better understand the neural chronometry of attention bias to threat.  
My Research Questions 
In light of emergent frameworks designed to narrow the gap between knowledge 
of clinical symptomology and dysregulated neurobiological systems, my research 
questions incorporate data from behavioral and neural measurement and treatment 
paradigms. Investigating these paradigms may help streamline attention-based 
interventions in youth with anxiety disorders. My research has thus developed along two 
lines. In the first line, I seek to identify the neural correlates (i.e., ERPs) of attention bias 
to threat in youth CBT nonresponders in order to identify neural markers for translational 
intervention research. In the second line, which builds on the first, I seek to examine the 
effects of ABMT on these neural markers and anxiety symptom severity in youth CBT 
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nonresponders. I expect these two lines of research will provide insight into (a) where in 
the stream of neural processing of threat youth anxiety CBT nonresponders experience 
perturbations and (b) whether ABMT remediates these perturbations. 
Dissertation Portfolio 
My dissertation portfolio includes three studies relevant to my two lines of 
research. In the first study (Study 1), I identified neural markers of attention to threat in 
youth anxiety CBT nonresponders. In this study, I compared ERP components (P1, N170, 
P2 and P3) as elicited by a dot probe task between CBT nonresponders with anxiety 
disorders and age-matched typically developing controls. I found that ERP components 
significantly differentiated youth with and without anxiety disorders, both in early-stage 
(P1, N170) and late-stage (P2, P3) attentional processing, while behavioral measures of 
attention to threat did not.  
Having identified neural markers in Study 1, I next will describe my efforts to 
pilot test a translational intervention designed to target these neural markers and reduce 
anxiety in youth CBT nonresponders (Study 2). Study 2 included six youth CBT 
nonresponders who completed a four-week course of ABMT; all youths completed 
sessions without any missed or rescheduled appointments. These youths also displayed 
significantly lower levels of anxiety symptoms following treatment.  
Having established the feasibility and acceptability of ABMT in youth anxiety 
CBT nonresponders in Study 2, I will conclude by describing my work to examine the 
influence of ABMT on neural makers of attention to threat in Study 3. In Study 3, I 
investigated changes in P1, N170, P2, and P3 components in N=30 youth CBT 
nonresponders who were randomly assigned to either a Control Task (CT, n = 16) or 
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active treatment (ABMT, n = 14). I found that ABMT led to significant increases in 
attentional processing for neutral facial stimuli as opposed to threat facial stimuli, as 
indicated by neural markers (ERP components P1, N170 and P3), at post-treatment and at 
eight weeks after the end of treatment.   
In summary, these three studies establish ERP markers elicited in the dot probe 
task that significantly distinguish youth anxiety CBT nonresponders from typically 
developing youth, the feasibility of ABMT as a promising adjuvant for CBT 
nonresponders in youth, and the influence of ABMT on ERP markers. Importantly, these 
studies also demonstrate significant anxiety reduction effects in ABMT, addressing the 
problem of 'what to do' with a treatment resistant population, CBT nonresponders.  
Current and Future Directions 
Now that I have examined the influence of ABMT on neural markers of attention 
to threat in youth anxiety CBT nonresponders, I envision multiple future directions. One 
important direction for future research will be to identify neural markers of attention to 
threat that prospectively predict CBT nonresponse in youth with anxiety disorders. The 
identification of such markers would inform the development and evaluation of adaptive 
strategies to intervene earlier with possible CBT nonresponders using ABMT. Instead of 
waiting for youth to complete and fail to respond to a full course of CBT, the presence of 
these neural markers may be used to initiate treatment ABMT monotherapy or concurrent 
CBT and ABMT. A second direction for future research will be to compare post-
treatment neural markers in ABMT responders to typically developing youth without 
anxiety disorders. This comparison would allow for a determination as to whether ABMT 
leads to a normalization of neural markers of attention to threat. Further, regarding the 
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directionality of attention training of ABMT (i.e., enhancement of attention for neutral 
stimuli within ABMT, as found in this dissertation) it is still unknown whether ABMT 
leads youth to identify threat more quickly and thus elicit more attention towards 
evaluation of neutral stimuli or whether youth with anxiety interpret neutral faces as 
threatening. Future studies should investigate this in the interest of refining ABMT. I 
intend to pursue these future directions and also expand my measurement approach to 
include neuroimaging of attentional networks in the context of ABMT in youth with 
chronically-impairing internalizing disorders.  
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Abstract 
Late-stage attentional processing of threatening stimuli, quantified through event-related 
potentials (ERPs), differentiates youth with and without anxiety disorders. It is unknown 
whether early-stage attentional processing of threatening stimuli differentiates these 
groups. Examining both early and late stage attentional processes in youth may advance 
knowledge and enhance efforts to identify biomarkers for translational prevention and 
treatment research. Twenty-one youth with primary DSM-IV-TR anxiety disorders (10 
males, ages 8-15 years) and 21 typically developing Controls (15 males, ages 8-16 years) 
completed a dot probe task while electroencephalography (EEG) was recorded, and ERPs 
were examined. Youth with anxiety disorders showed significantly larger (more positive) 
P1 amplitudes for threatening stimuli than for neutral stimuli, and Controls showed the 
opposite pattern. Youth with anxiety showed larger (more negative) N170 amplitudes 
compared with Controls. Controls showed significantly larger (more positive) P2 and P3 
amplitudes, regardless of stimuli valence, compared with youth with anxiety disorders. 
Event-related potentials observed during the dot probe task indicate youth with anxiety 
disorders display distinct neural processing during early stage attentional orienting and 
processing of faces; this was not the case for Controls. Such results suggest these ERP 
components may have potential as biomarkers of anxiety disorders in youth.  
 
Keywords: Event-related potential, youth, anxiety, attention. Abbreviations: DSM-IV-
TR: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text 
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Revision; ADIS for DSM-IV: C/P: Anxiety Disorders Interview Schedule for DSM-IV: 
Child and Parent Versions; ERPs: event-related potentials; EEG: electroencephalogram.  
 
Introduction 
Past research in children and adolescents (hereon referred to as youth) finds 
heightened attention to threatening stimuli in the development and maintenance of 
anxiety disorders (Mathews & MacLeod, 2002b; Mogg & Bradley, 1998; Vasey, 
Daleiden, Williams, & Brown, 1995; Waters, Mogg, Bradley, & Pine, 2008). Heightened 
threat processing, commonly documented via behavioral paradigms such as the dot probe 
task that measure attention bias (Bar-Haim, Lamy, Pergamin, Bakermans-Kranenburg, & 
van Ijzendoorn, 2007; Dudeney, Sharpe, & Hunt, 2015) is consistent with past work on 
information processing in youth anxiety  (Lonigan, Vasey, Phillips, & Hazen, 2004; 
Mogg & Bradley, 1998). Attention is the information processing function that allows 
individuals to identify and prioritize specific stimuli for elaborated processing, and 
attention bias refers to the tendency of anxious individuals to selectively allocate 
attention to threatening stimuli over non-threatening stimuli ( Pine, 2011). 
Youth studies using behavioral approaches such as the dot probe task demonstrate 
their utility in capturing reaction times to emotional stimuli in youth with anxiety (e.g., 
Price et al., 2013; Waters, Lipp, & Spence, 2004). However, behavioral paradigms such 
as the dot probe task assessing reaction times do not provide precise temporal 
information about where in the stream of attentional processing distinctions exist for 
anxious compared to typically developing (i.e., control) youth (Bar-Haim et al., 2007; 
White et al., 2016). The absence of precise temporal information in early attentional 
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stages has limited efforts to identify biomarkers that would more accurately inform 
translational prevention and treatment approaches (Price et al., 2013; Suway et al., 2013). 
It is unknown whether heightened attention to threat in anxious compared to non-anxious 
youth reflects differences in early stage orienting and vigilance, response selection, or 
late stage sustained attention. To advance understanding of the nature of these differences 
in attentional processing, particularly during the early stages, we examined event-related 
potentials (ERPs), elicited during a dot probe task in youth with and without anxiety 
disorders.   
Despite concerns about dot probe task reaction time score reliability (e.g., 
Kappenman, Farrens, Luck, & Proudfit, 2014), the dot probe can be leveraged with 
concurrent ERP assessment to capture temporally precise indices of neural activity within 
a fraction of a second. These neural data, time-locked to the presentation of emotional or 
neutral faces, may precisely indicate when attentional processes diverge for individuals 
with anxiety disorders compared with controls. An approach incorporating neural data as 
such is important because refined temporal knowledge about neural processes offered by 
ERPs (i.e., with larger component mean amplitudes representing greater allocation of 
neural resources) allows for consideration of specific early stage attentional processing 
components that may differentiate youth with anxiety disorders from controls. Such 
differentiations may lead to refinements in theoretical models of information processing 
disturbances in anxiety and may suggest biomarkers amenable to prevention and 
treatment. For example, the existence of early stage attentional processing markers would 
indicate a need to tailor attention training programs to target early stage orientation and 
vigilance instead of late stage sustained attention. Further, these components may be used 
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as outcome variables to examine the effectiveness of attention training programs that 
target attention to threat. 
In the ERP literature on early attentional processing, the majority of which has 
used adult samples, four ERP components have been identified as potentially relevant to 
threat and anxiety disorders, as measured with various behavioral paradigms: P1, P2, P3, 
and N170. The P1 is an early-stage component related to visuospatial attention to 
threatening faces (Mueller et al., 2009; Rossignol et al., 2012) and attentional orienting 
(utilizing the dot probe task; Eldar, Yankelevitch, Lamy, & Bar-Haim, 2010; Helfinstein, 
White, Bar-Haim, & Fox, 2008). The P2 is an early-stage component reflecting activity 
in response to emotional stimuli with relatively greater salience, especially negatively-
valenced stimuli ( Bar-Haim, Lamy, & Glickman, 2005; Carretié, Mercado, Hinojosa, 
Martín-Loeches, & Sotillo, 2004). The N170 is an early-stage component specifically 
related to processing of facial structures or formations (Balconi & Lucchiari, 2005; 
Eimer, 2000). The P3 is a relatively later-stage component (still within early attentional 
processing) related to strategic regulation of attention (e.g., Bruin, Kenemans, Verbaten, 
& Van der Heijden, 2000), response selection (Falkenstein, Hoormann, & Hohnsbein, 
1999) and response inhibition (Huster, Enriquez-Geppert, Lavallee, Falkenstein, & 
Herrmann, 2013).  
To date, no study has reported on ERP components associated with attentional 
processing of threat in youth with anxiety disorders and age-matched control youth using 
the dot probe task. Information processing models of threat stimuli in anxiety propose 
that individuals with anxiety disorders display attentional vigilance for potential threat 
cues in the environment and impaired regulation of attentional deployment to threat cues 
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(e.g., Yair Bar-Haim et al., 2007; Cisler & Koster, 2010). These models suggest distinct 
processes occurring early in the temporal stream of attentional processing. These early 
processes of orientation and vigilance for threatening faces can be assessed using the P1, 
N170 and P2 ERP components, while later regulation of attentional deployment to 
threatening faces can be quantified by the P3 component. The goal of the current study 
was to examine early and late stage attentional processing, using the dot probe task and 
specifically focusing on the P1, P2, P3, and N170 components, in youth with anxiety 
disorders and control youth.   
Research in non-referred samples of youths (and adults) suggests amplitudes in 
these ERP components during the dot probe task may be significantly associated with 
anxiety symptom severity. For example, P2 amplitudes during the dot probe task were 
significantly and positively associated with anxiety severity in a non-referred sample of 
adults (Eldar et al., 2010), and non-referred adults trained to attend to threatening stimuli 
displayed pre- to post-training increases in P2 amplitudes during the dot probe task 
(Suway et al., 2013). Further, P2 amplitudes during the dot probe task were significantly 
and negatively associated with social anxiety severity in a sample of non-referred youth 
at risk for anxiety (Thai, Taber-Thomas, & Pérez-Edgar, 2016). These research findings 
in non-referred samples highlight the complexity of the association between ERP 
components during the dot probe task and anxiety, and point to a pressing need to 
examine whether these ERP components during the dot probe task significantly differ 
between youth with and without anxiety disorders.  
The current study examined whether youth with anxiety disorders significantly 
differ from age-matched youth without anxiety disorders (Controls) on ERP components 
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associated with early and late stage attentional processing of threatening facial stimuli 
elicited by the dot probe task. Based on research reviewed above, we hypothesized that 
youth with anxiety disorders compared with age-matched controls would show (1) larger 
and more positive P1 and P2 amplitudes and more negative N170 amplitudes (i.e., early 
stage components) when viewing threatening stimuli compared with neutral stimuli, and 
(2) larger P3 amplitudes (i.e., late stage component) when viewing threatening stimuli 
compared with neutral stimuli. Such larger amplitudes would represent greater allocation 
of neural resources when attending to threatening stimuli.  
 
Method 
Participants 
Participants included two groups: 21 youths with anxiety disorders (Anxiety 
group) and 21 age-matched controls (Control group). The Anxiety group (N=21; mean 
age: 11.43 years [SD = 1.99], ages 8 to 15 years; 10 males [48%]) was recruited from a 
randomized clinical trial of Attention Bias Modification Training (R34 MH097931). All 
youths in the clinical trial were recruited to participate in the current EEG/ERP study at 
the baseline assessment of the clinical trial (i.e., before attention bias modification 
began). Youths from the clinical trial who agreed to participate in the current EEG/ERP 
study did not significantly differ from youths who declined on any variable of interest, 
including age, gender, anxiety severity, medication usage or presence of comorbid 
attention or behavior disorders. All youths in the Anxiety group met criteria for a current, 
primary DSM-IV-TR anxiety disorder (American Psychiatric Association, 2000): 
Generalized Anxiety Disorder (N=8), Social Phobia/Anxiety Disorder (N =6), Specific 
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Phobia (N =3), Separation Anxiety Disorder (N =3), and Obsessive-Compulsive Disorder 
(N =1). Ten youths (48%) in the Anxiety group met criteria for at least one comorbid 
anxiety disorder. Five youths in the Anxiety group met diagnostic criteria for a comorbid 
(non-primary) diagnosis of Attention-Deficit Hyperactivity-Inattentive type (ADHD-I), 
and three youths met diagnostic criteria for a comorbid (non-primary) diagnosis of 
Oppositional Defiant Disorder (ODD). Four youths in the Anxiety group were on a stable 
dose of medication at the time of assessment, for attention deficits (N =2) or for anxiety 
(N =2).  
The Control group (N=21; mean age: 11.52 years [SD = 2.25], ages 8 to 16 years; 
15 males [71%]) was recruited via email and flyers. Interested parents of potential 
Control youth participants completed phone or in-person screening interviews, including 
screener questions from the Kiddie Schedule for Affective Disorders and Schizophrenia 
(K-SADS; Kaufman et al., 1997)  to confirm that youths did not currently meet criteria 
for and had never been diagnosed with or treated for neuropsychological, emotional or 
behavioral disorders, including cognitive impairment, depression, anxiety, ADHD, 
conduct disorder, or eating disorders. Master’s and doctoral level students, trained in the 
screening protocol, completed screening interviews and made eligibility determinations 
under the close supervision of the project PIs. 
All procedures were approved by the appropriate Institutional Review Board. 
Informed consent was obtained from all individual participants included in the study. 
Parents provided informed consent, and youths provided assent. 
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Diagnostic Measure  
Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent 
Versions (ADIS-IV:C/P; Silverman & A. M. Albano, 1996). The ADIS-IV: C/P is a 
semi-structured interview designed to assess anxiety and related disorders in youth. 
Master’s and doctoral level graduate students, trained in administration and scoring 
protocol (having completed didactic instruction, hands on demonstration and role play, 
and testing out in the assessment protocol), administered the ADIS-C/P to each child and 
parent in the Anxiety group; diagnoses were given when one or both informants met 
diagnostic criteria. Before conducting interviews, evaluators met a 100% reliability 
criterion on five videotaped child-parent assessments. The ADIS-IV: C/P yields retest 
reliability kappas between .80 to .92 for diagnoses, and significant associations with 
youth anxiety ratings (e.g., Silverman, Saavedra, & Pina, 2001). 
Anxiety Severity Ratings  
All youth participants and their parents (usually the mother) were administered 
the Screen for Child Anxiety Related Emotional Disorders-Child and Parent Versions 
(SCARED-C/P). 
SCARED-C (SCARED-C; Birmaher et al., 1999; Birmaher et al., 1997). The 
SCARED-C consists of 41 items on which youth rate anxiety symptoms on a three-point 
scale. Test-retest reliability is satisfactory to excellent (ranging from .70 to .90). The 
SCARED-C has demonstrated good convergent and divergent validity compared with 
other widely used screening scales (Birmaher et al., 1999; Birmaher et al., 1997). In this 
sample, the alpha coefficient was .91. 
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SCARED-P (SCARED-P; Birmaher et al., 1999; Birmaher et al., 1997). The 
SCARED-P consists of 41 items on which parents rate youth anxiety symptoms on a 
three-point scale. The reliability and validity of the SCARED-P have been demonstrated 
repeatedly and mirror those of the SCARED-C (Birmaher et al., 1999; Birmaher et al., 
1997). In this sample, the alpha coefficient was .96. 
Past studies in this area have either examined SCARED-C and SCARED-P scores 
separately (e.g., Wren et al., 2007), or have averaged child and parent ratings to examine 
a single SCARED-C/P score (Roy et al., 2013). To facilitate comparison with all past 
studies in this area and build the literature on approaches to using ratings from different 
informants, we separately report on SCARED-C, SCARED-P, and averaged SCARED-
C/P scores.   
Dot-Probe Task   
 The emotional faces dot-probe task developed by MacLeod, Mathews & Tata 
(1986), modified for use in child anxiety studies (TAU-NIMH ABMT initiative; 
http://people.socsci.tau.ac.il/mu/anxietytrauma/tau-nimh-abmt-initiative-participating/), 
was used to obtain a behavioral measure of attentional bias towards threatening stimuli.  
In each trial, a white fixation cross appeared for 500 milliseconds (ms) in the 
center of the screen, followed by a pair of faces (chromatic) appearing for 500 ms. The 
pair of faces of the same actor showing a neutral or angry (i.e., threatening) expression 
(Tottenham et al., 2009) appeared on the top and bottom of the screen. In each trial, the 
pair of faces displayed was one of three combinations (80 neutral-angry, 80 angry-
neutral, or 80 neutral-neutral) for a total of 160 neutral-threat (NT) trials and 80 neutral-
neutral (NN) trials. Immediately following the faces, a probe (“<” or “>”) appeared in the 
 16 
 
location of either the top or bottom face. Participants were instructed to indicate the 
orientation of the probe by clicking the left or right mouse button (left for “<”, right for 
“>”) using their dominant hand. Stimuli (chromatic photographs of same-actor face pairs, 
45 mm in width and 34 mm in height) were presented with a laptop with a 14-in monitor. 
The probe remained on-screen until the participant responded or for 1000 ms, response 
was followed by an inter-trial interval (500 ms), and then the next trial began 
immediately. Angry-face location, probe location, probe type, and actor were fully 
counterbalanced in presentation. The importance of completing the task as quickly as 
possible without compromising accuracy was emphasized. Trials were presented using E-
Prime software (Psychology Software Tools, Pittsburgh, PA).  
Responses on the dot-probe task were used to calculate mean reaction times (RT) 
on trials, total number of accurate trials, and attention bias scores. Trials in which the 
probe replaced the angry face were considered congruent trials, and trials in which the 
probe replaced the neutral face were considered incongruent trials. Bias scores were 
computed as reaction time differences of incongruent minus congruent trials. Positive 
attention bias scores indicated a bias toward angry faces (i.e., threat) and negative values 
indicated a bias away from threat. Inaccurate responses, trials with response latencies 
<150 ms and >1200 ms, and trials with response latencies +/- 2.5 SDs from the 
participant’s mean were excluded (e.g., Eldar et al., 2010).   
Electrophysiological Recording  
 Each participant was fitted with a 64-electrode elasticized nylon cap (WaveGuard; 
Advanced Neuro Technology, Enschede, Netherlands) with sewn-in Ag/AgCl shielded 
electrodes following the international 10-20 electrode system. The raw signal was 
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amplified by 25,000 using a high-input impedance AsaLab amplifier (Advanced Neuro 
Technology, Enschede, Netherlands). The EEG data was sampled at 1024 Hz with a 
high-pass filter of .3 Hz. Data acquisition began once impedance values were below 50 
kΩ (a resistance level used for studies in comparable age ranges; Thai et al., 2016). 
During recording, ERPs were referenced to CPz, and AFz served as the ground electrode. 
The EEG data were further analyzed offline using EEGLAB (Delorme & Makeig, 2004) 
and ERPLAB (Lopez-Calderon & Luck, 2014) software. 
 Event-related potentials. In post-processing, EEG data were re-referenced to 
average reference and re-filtered with a low-pass filter of 30 Hz. Data were baseline-
corrected to the average voltage during the 100 ms prior to stimulus onset (i.e., each trial 
of angry and neutral faces). Data were resampled offline at 512 Hz. Ocular and motor 
artifacts exceeding ±75 mV were rejected. Data were segmented and visually inspected 
for additional ocular and motion artifact. Epochs containing blink activity were removed 
as electrooculogram (EOG) contamination. Trials consisted of a 100 ms baseline period 
and 500 ms period following onset of facial stimuli.  Boxplots for numbers of NT and NN 
trials remaining after rejection were inspected for outliers; an outlier was defined as 
scores >2 SD from the mean on both the NT and NN amplitude of a particular component 
(P1, P2, P3, N170) at a particular site (POz, Oz). No outliers were identified. 
 Stimulus-evoked ERP components. Specific components of interest were P1, 
N170, P2, and P3. In line with previous pediatric (Batty & Taylor, 2006; O'Toole, 
DeCicco, Berthod, & Dennis, 2013; Segalowitz, Santesso, & Jetha, 2010) and adult 
(Eldar et al., 2010; Mühlberger et al., 2009) ERP studies, P1, N170, P2, and P3 
components were examined at midline parieto-occipital sites POz and Oz. Mean number 
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of epochs remaining after artifact rejection (NT, NN), used to generate grand averaged 
wave forms, were comparable (ps > .644) across Control (NT: M =111.95, SD = 24.91; 
NN: M =54.57, SD = 13.42) and Anxiety (NT: M =110.19, SD = 23.76; NN: M =56.43, 
SD = 12.48) groups. Each participant’s grand average waveforms were visually inspected 
to determine the window in which the maximal peak of each proposed component was 
found. Exhaustive windows were shaped by minima and maxima of peak onset ranges 
recorded per participant, and group-wise grand averages were inspected for each 
component to confirm the latency windows included all participants’ components. Non-
overlapping latency windows for P1 (100-160 ms), N170 (170-230 ms), P2 (230-280 ms), 
and P3 (300-380 ms) were generated separately in ERPLAB and individual mean 
amplitudes and peak latencies for each component were imported into statistical software 
program SPSS version 22.0 (SPSS, 2013) for statistical analysis.  
Statistical Analysis  
 Independent samples t-tests were used to examine group differences on age, 
attention bias reaction time (RT) scores and SCARED-C/P scores; a chi-square analysis 
was used to examine gender distribution across groups. Initial analyses employed a 2 x 2 
x 2 Analysis of Covariance (ANCOVA) with site (POz, Oz) and stimulus (trial type: NT 
or NN) as within-subjects factors and group (Control or Anxious) as the between-subjects 
factor. A priori decisions were made to include current medication status and comorbid 
ADHD-I diagnosis as covariates as these may significantly affect attentional processes 
(Weissman, Chu, Reddy, & Mohlman, 2012). Additionally, age was included as a 
covariate to adjust for possible developmental effects on attentional processes. We 
utilized used the Greenhouse-Geisser correction method for corrections of violations of 
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sphericity. For the majority of components, a significant main effect of site was found 
(P1: F[1,37] = 13.09, p = .001, ηp2 = .261; N170: F[1,37] = 4.59, p = .039, ηp2 = .036; P3: 
F[1,37] = 5.11, p = .030, ηp2 = .110; P2:  F[1,37] = 2.20, p=.146, ηp2 = .056), therefore, 
all subsequent analyses examined effects at Oz and POz separately. For each ERP 
component, mean amplitude and peak latency were separately subjected to a 2 x 2 
Analysis of Covariance (ANCOVA) with stimulus (trial type: NT or NN) as within-
subjects factor and with group (Control or Anxious) as between-subjects factor, with the 
three covariates described above. Post-hoc analyses were used to examine significant 
interaction and main effects.   
Results 
Attention to Threat and Anxiety Severity Ratings 
Groups did not significantly differ by age, t(40) = .145, p = .885, d = .04, or 
gender, χ2(1) = 2.47, p = .116. Mean RTs, accuracy scores and threat bias scores on the 
dot probe task and mean scores on the SCARED-C/P are presented in Table 1. Compared 
to the Control group, the Anxiety group displayed significantly higher scores on the 
SCARED-P, t(40) = -5.17, p <.001, d = 1.60, and the averaged SCARED-C/P, t(40) = -
4.077, p = <.001, d = 1.26, but not SCARED-C, t(40) = -.930, p = .358, d = .28. Mean 
RTs, accuracy, and bias scores on the dot probe task did not differ significantly between 
groups (ps >.793).  
Electrophysiological Data: early-stage attentional processing. Figure 1(a) shows scalp 
distributions of mean amplitudes during NT trials across Anxiety and Control groups, and 
Figures 1(b) and 1(c) present grand average waveforms during NT trials for Anxiety and 
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Control groups at sites POz and Oz, respectively. Figures 2(a), 2(b) and 2(c) present the 
same information as Figures 1(a-c) for NN trials.  
P1. No significant main effects for P1 mean amplitude were found at POz or Oz. 
The stimulus (NT vs NN) by group (Anxiety vs Control) interaction effect for P1 mean 
amplitude was statistically significant at POz, F(1,37) = 4.06, p = .05, ηp2= .10. P1 
amplitude was more positive during NN trials in the Control group (M = 18.78, SE = 
2.61) than the Anxiety group (M = 17.09, SE = 2.12) (Figure 1b). In contrast, P1 
amplitude was more positive during NT trials in the Anxiety group (M = 18.08, SE = 
2.15) than the Control group (M = 17.93, SE = 2.61) (Figure 2b). No significant main 
effects of group were found in post-hoc analyses for stimulus type, NT: F(1,37) = .030, p 
= .863, ηp2= .001; NN: F(1,37) = .244, p = .624, ηp2= .007. No significant main or 
interaction effects for peak latency were found at POz or Oz.  
N170. The main effect for group on N170 mean amplitude was statistically 
significant at Oz, F(1,37) = 4.69, p = .037, ηp2= .113, as was the main effect of stimulus 
type (NT vs NN), F(1,37) = 5.69, p = .022, ηp2= .133 (Figures 1c, 2c). Collapsed across 
stimulus types, N170 amplitude was significantly more negative for the Anxiety group 
(NT: M = -6.40, SE = 12.19, NN: M = -5.71, SE = 11.88) than the Control group (NT: M 
= -1.68, SE = 8.68, NN: M = -2.21, SE = 9.48). Collapsed across groups, N170 amplitude 
was significantly more negative during NT trials than during NN trials. A significant 
main effect of stimulus type was also found for peak latency, F(1,37) = 7.24, p = .011, 
ηp2= .164, with peak onset occurring significantly faster for NT trials (Control M = 
201.73, SE = 13.79, Anxiety M = 202.85, SE = 18.84) than NN trials (Control M = 
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202.47, SE = 14.66, Anxiety M = 205.26, SE = 18.28). No significant main or interaction 
effects for N170 mean amplitude or peak latency were found at POz. 
P2. The main effect of group on P2 mean amplitude was statistically significant at 
Oz, F(1,37) = 4.33, p = .044, ηp2= .105 (Figures 1c, 2c). Collapsed across stimulus types, 
P2 amplitude was significantly more positive for the Control group (NT: M = 5.70, SE = 
8.82, NN: M = 5.77, SE = 9.01) than the Anxiety group (NT M = .092, SE = 12.10, NN: 
M = -.004, SE = 14.65). No significant interaction or main effects were found for P2 peak 
latency. No significant main or interaction effects for P2 mean amplitude or peak latency 
were found at POz. 
Electrophysiological Data: late-stage attentional processing 
P3. The main effect of group on P3 mean amplitude was statistically significant at 
Oz, F(1,37) = 4.43, p = .042, ηp2= .107 (Figures 1c, 2c). Collapsed across stimulus types, 
P3 amplitude was significantly more positive for the Control group (NT: M = 7.18, SE = 
5.31, NN: M = 7.12, SE = 6.53) than the Anxiety group (NT M = 3.88, SE = 11.51, NN: 
M = 2.65, SE = 10.87). No significant main or interaction effects were found for P3 peak 
latency. No significant main or interaction effects for P3 mean amplitude or peak latency 
were found at POz. 
Discussion 
This is the first study to examine neural correlates of attentional processing to 
threatening and non-threatening facial stimuli elicited by the dot probe task in youth with 
and without anxiety disorders. Our findings indicate that ERP neural responses reflecting 
early and late attentional processing, across neutral and threatening facial stimuli, 
differentiate youth with and without anxiety disorders. For early attentional processing, 
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P1 amplitude was larger for threatening stimuli than for neutral stimuli in the Anxiety 
group, whereas the opposite pattern was observed in the Control group. N170 amplitudes 
were significantly larger (more negative) in the Anxiety group than in the Control group. 
P2 was significantly larger in the Control group than in the Anxiety group. For late 
attentional processing, P3 was significantly larger in the Control group than in the 
Anxiety group.  
Consistent with information processing theories of anxiety, our findings provide 
evidence of distinct neural processing of facial and/or threatening stimuli in youth with 
anxiety disorders during attentional stages corresponding to attentional orienting, face 
recognition and threat detection and, at a later stage, to attentional regulation. The general 
pattern of findings aligns with previous findings in adults’ ERP components elicited by 
emotional face tasks, including the dot probe task (Bar-Haim et al., 2005; Helfinstein et 
al., 2008), probe discrimination task (Eldar, Yankelevitch, Lamy & Bar-Haim, 2010) and 
emotional Flanker task (Dennis & Chen, 2009; Moser, Huppert, Duval & Simons, 2008), 
in which both early stage attentional processing related to threat identification and later 
stage attentional processing related to inhibition were significantly associated with 
anxiety.  However, as we elaborate below, specific findings on individual components 
differ from what has been reported in samples of adults and one sample of children.  
Youth with anxiety disorders devoted relatively more early attentional resources 
when orienting towards threatening facial stimuli (i.e., relatively larger P1) and when 
processing faces regardless of emotional valence (i.e., relatively larger N170 amplitudes) 
compared to Controls. In contrast, youth with anxiety disorders devoted fewer attentional 
resources to processing of emotion (i.e., relatively smaller P2) and late-stage attentional 
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regulation (i.e., relatively smaller P3) than Control youth. These findings suggest youth 
with anxiety respond differentially to emotional stimuli in very early processing (i.e., at 
P1) but do not differentiate emotional face type in later processing (i.e., at N170, P2 and 
P3); that is, the findings for N170, P2, and P3 were not specific to threatening faces. 
Further, these findings suggest that relative to controls, youth with anxiety disorders 
show greater use of resources for face recognition and reduced use of resources in late 
stage attentional regulation. Lower amplitudes for ERP components after early attentional 
orienting (P2 and P3) in youth with anxiety disorders, and not in controls, may suggest 
relatively less developed attentional processing (i.e., poorer attentional control; Susa, 
Pitică, Benga, & Miclea, 2012) in anxious youth. The current results partially contrast 
with a recent ERP study in youth with behavioral inhibition (BI), which found early 
components of attention, such as P1 and N170, are relatively insensitive to emotional 
content in the dot probe task (Thai et al., 2016); youth in our sample responded to 
emotional content in very early processing (i.e., P1) and did not respond to emotional 
content in later processing (i.e., N170, P2 & P3). Further, in the Thai et al. (2016) study, 
youth with and without BI were not differentiated by P1, and the current study found 
youth anxiety showed higher P1 in response to threat stimuli compared with controls.  
The results found for P1 extend previous findings in nonreferred youth using 
different emotional face tasks (e.g., Batty & Taylor, 2006; Taylor, Edmonds, McCarthy, 
& Allison, 2001) to youth with anxiety disorders, further demonstrating that the P1 
component may be sensitive to emotional versus non-emotional facial stimuli. Our results 
are also consistent with previous work linking P1 to increased attentional processing of 
emotional faces in youth with anxiety (Batty & Taylor, 2003; Hum, Manassis, & Lewis, 
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2013) and adults with anxiety (Holmes, Nielsen, & Green, 2008; Mueller et al., 2009; 
Pourtois, Dan, Grandjean, Sander, & Vuilleumier, 2005).   
The current findings for N170 extend previous adult and child anxiety work that 
showed enhanced N170 components for threat stimuli (e.g., Balconi & Lucchiari, 2005; 
Bentin, Allison, Puce, Perez, & McCarthy, 1996; Eimer, 2000; Kolassa & Miltner, 2006; 
Mueller et al., 2009; O'Toole et al., 2013). Compared to Control youth, we observed that 
youth with anxiety disorders exhibited significantly larger (more negative) N170 mean 
amplitudes when viewing both threatening and neutral stimulus trials. Threat trials also 
elicited larger N170 (more negative) responses than neutral trials. It is possible that these 
components elicited in the dot probe task are more strongly associated with the current 
presence of an anxiety disorder (as we observed) than future risk for developing an 
anxiety disorder (i.e., behavioral inhibition). This possibility of strong neural-behavioral 
association is consistent with the finding that young children with heightened anxiety and 
enhanced N170 responses to threat faces displayed higher symptoms of anxiety later in 
childhood (O'Toole et al., 2013). 
Past research in youth with BI, not anxiety disorders, found a significant 
association between larger P2 responses to faces in general (neutral and threat combined; 
Thai et al., 2016). Control youth in the present study showed a similar pattern, suggesting 
that larger P2 responses to faces in general may be normative in youth who do not 
currently experience severe levels of anxiety. In contrast, youth with anxiety disorders 
displayed smaller P2 responses to faces in general. If replicated, this smaller P2 response 
to faces in youth with anxiety disorders may indicate dampened allocation of attentional 
resources to emotionally salient facial stimuli at this stage of processing. The P2 findings 
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in this study differ from previous work in adults using the dot probe, with populations 
with anxiety showing larger P2 responses to threat (O’Toole & Dennis, 2012; Suway et 
al., 2013). Possibly, sensitivity to threatening facial stimuli, indexed by the P2, develops 
in later adolescence or early adulthood. 
The P3 component, as with the P2, was larger in Controls compared to youth with 
anxiety disorders, regardless of stimulus type. Ours was the first study to report larger 
P3s in control youth. Past research in nonreferred adults found the P3 component 
differentiates emotional content of faces (Holmes et al., 2008; Moser, Huppert, Duval, & 
Simons, 2008; Pourtois, Grandjean, Sander, & Vuilleumier, 2004), with adults showing 
larger P3 components when viewing neutral stimuli. Such differentiation of emotional 
valence was not found in the current study. The discrepancy in findings across youth and 
adult samples could reflect developmental differences, clinical status differences or 
paradigm differences. However, framed within the literature on sustained attentional 
processing and regulation, and as P3 was higher in Controls than in youth with anxiety 
disorders (as with P2), this finding is consistent with work in adults linking enhanced P3 
with stimulus evaluation and with response selection (Falkenstein, Hohnsbein, & 
Hoormann, 1994; Verleger, 1997). Our P3 finding further indicates that late-stage 
attentional regulation in typically developing youth appears more consistent with that of 
adults. Studies of P3 in children with anxiety disorders suggest that P3 is enhanced when 
youth must process and inhibit task-irrelevant stimuli with high emotional valence 
(Éismont, Lutsyuk, & Pavlenko, 2009). In the dot probe task, all facial stimuli are task-
irrelevant. Thus, a relatively higher P3 during all trials may suggest typically developing 
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youth devote more attentional resources to late-stage processing emotional facial stimuli 
than youth with anxiety disorders. 
We know of only one study that has reported on ERP components in youth with 
and without anxiety disorders using an emotional face-matching task (Kujawa, 
MacNamara, Fitzgerald, Monk, & Phan, 2015). Specifically, users were required to select 
which of two faces (neutral and emotional) matched a given emotional face. After 
examining three latency windows (early, middle and late) of the late positive potential 
(LPP), Kujawa and colleagues found that late stage LPP was enhanced following angry 
and fearful faces (1000-2000 ms) in those with anxiety disorders but not in those without. 
The Kujawa et al., (2015) study demonstrated youths with anxiety disorders exhibit 
distinct markers in late stage, sustained attentional processing of emotional stimuli. 
Measurement of the LPP in the present study was not feasible (given trial length of the 
dot probe task does not typically exceed 1000-1500 seconds), preventing direct 
comparisons between the results of the current study and the results of the LPP study. 
However, taken together, both studies’ results suggest both early and late stage 
attentional processing components may be promising markers of threat processing in 
youth with anxiety disorders. Future research on the dot probe should include longer trial 
durations in order to examine the LPP in addition to earlier stage components.  
As in some other studies in youth (Benoit, McNally, Rapee, Gamble, & Wiseman, 
2007; Price et al., 2013; Salum et al., 2013), no between groups differences were found 
on a behavioral reaction time measure of attention bias to threat. Reaction time measures 
on the dot-probe task may be insensitive to attention-related processes because motor 
output on attention tasks arises from a complex series of processes, only some of which 
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are related to individual differences in anxiety (MacNamara, Kappenman, Black, Bress, 
& Hajcak, 2013; White et al., 2016). The present findings indicate that ERP components 
elicited in the dot-probe task are sensitive to attention-related processes in youth and thus 
hold greater promise as potential biomarkers for translational prevention and treatment 
research.  
 Current findings should be evaluated in light of the study’s limitations. One 
limitation was relatively small sample size, which limited statistical power and prevented 
us from examining possible individual differences in ERP amplitudes as function of age, 
sex, anxiety severity or diagnostic category and warrants caution in interpretation of 
results. The age range of the current study, spanning across puberty, may have limited 
our ability to account for the influence of this developmental stage. A second limitation 
was the inclusion of youth with a range of primary anxiety disorders, including specific 
phobia, a disorder less linked with attention bias to threat. A third limitation was that we 
relied on a relatively brief window for attention processing (500 ms), which is in part a 
result of the duration of stimulus presentation within the dot probe task. Given the current 
study design and the relatively brief presentation length of the facial stimuli, this current 
study was unable to assess neural correlates of late-stage attentional processing such as 
the LPP. Future studies are encouraged to consider very late stage attentional processing 
of threat, especially in light of evidence that the LPP ERP component may significantly 
differ between clinic-referred youth with anxiety disorders (Kujawa et al., 2015).  
In summary, the current study provides evidence that youth with anxiety disorders 
significantly differ from typically developing youth in early and late neural correlates of 
attentional processing of threatening and non-threatening facial stimuli. These results do 
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not only indicate heightened attention to threat stimuli in anxiety but also indicate larger 
attentional responses in early processing and blunted responses in later processing. The 
neural components (P1, N170, P2, and P3) observed within the context of the dot probe 
task hold promise as biomarkers in youth for translational prevention and treatment 
research. Future research is encouraged to investigate these potential biomarkers, 
including their sensitivity to attention training regimens designed to reduce anxiety (e.g., 
Attention Bias Modification Training; Yair Bar-Haim, 2010). 
Ethical Approval 
All procedures performed in studies involving human participants were in accordance 
with the ethical standards of the institutional and/or national research committee and with 
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Table 1. Age, Behavioral Questionnaire and Dot Probe task scores. SCARED-P/C = Screen for Child Anxiety Related 
Emotional Disorders, Parent & Child reports, M = mean, RT = reaction time, SD = standard deviation. α = 0.05.  
 Control 
Mean (SD) 
Anxiety 
Mean (SD) 
t df p d 
SCARED-P 7.52 (7.25) 28.05 (16.67) -5.17 40 <.001 1.52 
SCARED-C 16.62 (12.12) 24.14 (13.17) -.93 40 .36 .59 
Dot Probe Threat Bias Score -1.82 (14.01) -3.89 (19.60) .39 37 .70 .12 
Dot Probe Accuracy (%)  95.60 (.04) 95.46 (.09) .07 40 .95 2.01 
Dot Probe RT (ms)  561.33 (95.23) 569.00 (93.08) -.26 40 .79 .08 
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Table 2. Mean amplitudes and peak latency measures across Anxiety and Control groups for components N170, P1, P2 and P3 
(sites POz & Oz). 
  Anxiety 
Mean (SD) 
 
Control 
Mean (SD) 
Site POz  Oz  POz  Oz 
 NT NN  NT NN  NT NN  NT NN 
Mean Amplitude (µV)            
     N170 -6.40 (12.2) -5.71 (11.9)  6.03 (14.3) 6.57 (13.6)  -1.68 (8.7) -2.21 (9.5)  9.22 (9.4) 9.18 (10.9) 
     P1 7.24 (7.4) 6.45 (7.0)  18.08 (9.6) 17.09 (9.2)  9.51 (7.4) 10.34 (8.6)  17.93 (12.2) 18.78 (12.5) 
     P2 .09 (14.1) 0 (14.7)  9.82 (11.7) 9.97 (13.1)  5.70 (8.8) 5.77 (9.0)  13.14 (10.7) 14.24 (11.1) 
     P3 3.88 (11.5) 2.65 (10.9)  10.93 (9.7) 10.91 (10.9)  7.18 (5.3) 7.12 (6.5)  14.11 (7.2) 14.37 (8.2) 
Peak Latency (ms)            
     N170 202.85 (18.8) 205.26 (18.3)  199.13 (23.2) 196.80 (21.9)  201.73 (13.8) 202.47 (14.7)  201.54 (17.0) 199.78 (18.6) 
     P1 131.70 (14.9) 131.23 (16.4)  131.98 (13.6) 130.02 (14.0)  137.18 (11.6) 132.44 (15.2)  134.58 (11.4) 136.53 (12.0) 
     P2 261.53 (16.4) 263.86 (18.4)  253.91 (16.7) 254.28 (19.2)  256.98 (15.5) 255.67 (16.0)  249.44 (16.9) 252.60 (16.9) 
     P3 336.03 (25.6) 338.82 (23.2)  340.03 (24.2) 344.12 (25.2)  340.59 (25.1) 338.08 (19.2)  339.66 (25.9) 339.01 (23.0) 
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Fig. 1 Grand average mean amplitude ERPs for youth with Anxiety versus Control youth during NT trials, (a) at all sites; 
grand average waveforms during NT trials across both groups (b) at site POz, and (c) at site Oz.   
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Fig. 2 Grand average mean amplitude ERPs for youth with Anxiety versus Control youth during NN trials, (a) at all sites; 
grand average waveforms during NN trials across both groups (b) at site POz, and (c) at site Oz.   
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Abstract 
Evidence is emerging to support the promise of Attention Bias Modification Treatment 
(ABMT), a computer-based attention training program, in reducing anxiety in children. 
ABMT has not been tested as an adjuvant for children with anxiety disorders who do not 
respond to Cognitive-Behavioral Therapy (CBT). This case series presents findings from 
an open trial of ABMT among six children (four girls; M age=11.2 years) who completed 
a CBT protocol and continued to meet diagnostic criteria for an anxiety disorder. All 
children completed the ABMT protocol with no cancelled or missed sessions. Child self-
ratings on anxiety symptoms and depressive symptoms significantly decreased from 
pretreatment to posttreatment, as did parent ratings on child anxiety-related impairment. 
Parent ratings on child anxiety and internalizing symptoms displayed non-significant 
decreases from pretreatment to posttreatment. These findings support the potential 
promise of ABMT as a feasible adjuvant treatment that reduces anxiety and impairment 
among child anxiety CBT nonresponders. 
 
Keywords: Anxiety; Children; Attention; Treatment; Attention bias 
 
Introduction 
 Anxiety disorders occur in 10% to 20% of children and adolescents, pose a huge 
financial burden on the healthcare system, and are associated with substantial 
impairment(Rapee, Schniering, & Hudson, 2009; Silverman, Pina, & Viswesvaran, 
2008).Evidence-based treatments for anxiety in children and adolescents are largely 
exposure-based cognitive behavioral therapies (CBTs; Rapee et al., 2009; Silverman et 
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al., 2008). Despite the strong efficacy evidence for CBT, up to50% of children and 
adolescents continue to meet diagnostic criteria for an anxiety disorder after a full course 
of treatment (Compton et al., 2004; Rapee et al., 2009; Silverman et al., 2008). To our 
knowledge, no empirical study has examined an adjuvant treatment for children and 
adolescents who did not benefit from CBT. In this article, we report promising 
preliminary data on Attention Bias Modification Treatment (ABMT) as an adjuvant for 
children and adolescents who completed a full course of CBT and continued to meet 
diagnostic criteria for an anxiety disorder.  
 Threat-related attention bias has been implicated in the development, etiology and 
maintenance of anxiety disorders (Bar-Haim, Lamy, Pergamin, Bakermans-Kranenburg, 
& van IJzendoorn, 2007; Cisler & Koster, 2010; Eldar, Ricon, & Bar-Haim, 2008; 
Mathews & MacLeod, 2002).The most commonly used paradigm for assessing threat-
related attention bias is the visual probe-detection task. In the task, a pair of threatening 
and neutral stimuli is presented simultaneously and then followed immediately by a 
visual probe. The probe replaces the threatening stimulus on some trials and the neutral 
stimulus on others. An individual’s difference in average response times when identifying 
the location of the probe following threatening stimuli versus neutral stimuli provides an 
index of attention bias.  
Anxious individuals typically display faster response times on trials in which the 
probe replaces the threatening stimuli, which reflects an attention bias toward threat (Bar-
Haim et al., 2007). This pattern has been replicated among children(e.g., Vasey, el-Hag, 
& Daleiden, 1996), adolescents (e.g., Telzer et al., 2008), and adults (e.g., Mogg, 
Philippot, & Bradley, 2004), including youth and adult patients with Social Phobia (SOP; 
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e.g., Roy et al., 2008) and Generalized Anxiety Disorder (GAD; e.g., Waters, Mogg, 
Bradley, & Pine, 2008), youth patients with Separation Anxiety Disorder (SAD; e.g., 
Waters, Henry, Mogg, Bradley, & Pine, 2010), and youth and adults with subclinical 
anxiety symptoms (e.g., Mogg & Bradley, 2002).  
In response to the well documented role of attention bias to threat in anxiety and 
its disorders, researchers have developed computer-based attention training programs to 
reduce  anxiety (Amir, Beard, Burns, & Bomyea, 2009; Eldar et al., 2012; Schmidt, 
Richey, Buckner, & Timpano, 2009). ABMT is based on the idea that attention bias can 
be shaped via repetitive computer based training methods, although the mediators of 
ABMT’s anxiety reduction effects require further empirical testing (Bar-Haim, 2010). In 
ABMT, patients complete the visual-probe detection task described above, with the 
critical exception that the probe always or almost always replaces the neutral stimulus 
and not the threatening stimulus. 
ABMT has shown promising anxiety reduction effects in clinic referred adults 
and children (Eldar et al., 2012; Hakamata et al., 2010).Three attention training studies 
have been conducted with clinic referred samples of children and adolescents with 
anxiety disorders (Cowart & Ollendick, 2011; Eldar et al., 2012; Rozenman, Weersing, & 
Amir, 2011).Findings from these studies support the feasibility and promise of ABMT as 
a frontline treatment for children and adolescents with anxiety disorders. Whether ABMT 
would demonstrate similar feasibility and promise as an adjuvant among children and 
adolescents with anxiety disorders who do not respond to CBT is an unaddressed 
empirical issue. This is an important issue, however, given, as noted above, that up to 
50% of anxious children and adolescents who receive CBT fail to benefit.  
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The purpose of the current case series was to examine preliminarily the feasibility 
and potential promise of ABMT as an adjuvant treatment for children and adolescents 
who still met criteria for anxiety disorder diagnosis following a full course of CBT. Six 
children (four girls) identified as nonresponders following a 12 to 14 week CBT protocol 
completed an open trial of ABMT. Nonresponse was operationally defined as continuing 
to meet criteria for a primary diagnosis of GAD, SAD, or SOP at the posttreatment and 
12 month follow up evaluations in the parent CBT trial. Consistent with most past ABMT 
research (Amir, Beard, Burns, et al., 2009; Amir, Beard, Taylor, et al., 2009; Schmidt et 
al., 2009), participants completed a pretreatment assessment followed by eight sessions of 
ABMT over four weeks, and then completed a posttreatment assessment. Outcomes 
included child self ratings and parent ratings on anxiety and related impairment. To 
determine whether ABMT had a general effect on negative emotions or a specific effect 
on anxiety, child self ratings on depressive symptoms also were collected. 
 
1. Method 
1.1. Participants 
Participants were recruited from a large, ongoing clinical trial of CBT for children 
and adolescents with GAD, SOP, or SAD. All potential participants had completed a 12-
14 week CBT protocol similar to that used in previous trials(see Silverman, Kurtines, 
Jaccard, & Pina, 2009). At the time of this study, approximately 190 participants had 
enrolled in the CBT trial and approximately 120 participants had completed the full CBT 
protocol, a posttreatment assessment, and a 12-month follow up assessment (M age at 
follow up= 11 years; 47% girls; 81% Hispanic).Youth were eligible for ABMT if they 
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were between ages 8 to 14 years and met criteria for a primary DSM-IV diagnosis of 
GAD, SOP, or SAD at post and 12-month follow-up assessments of the CBT protocol. 
Exclusion criteria were (a) meeting diagnostic criteria for Organic Mental Disorders, 
Psychotic Disorders, Pervasive Developmental Disorders, or Mental Retardation, (b) 
showing high likelihood and/or serious intent of self-harm; (c) not living with a primary 
caregiver who was legally able to give consent for participation, (d) having a serious, 
uncorrected vision problem and (e) having a physical disability which interfered with the 
child’s ability to click a mouse button rapidly and repeatedly. Children with comorbid 
ADHD, minimally impairing tics or impulse control problems or depressive disorders 
were eligible, as long as the comorbid disorder was treated with medication and stable.  
Of the children who had completed 12-month follow up assessment and met 
inclusion criteria for the present study, ten were identified, and attempts were made to 
contact their families to inform them about this new treatment opportunity. Eight families 
were contacted, and six families agreed to participate. Two families declined and cited 
distance and travel time as the reason; the remaining two families could not be reached. 
The six participants (four girls, two boys) ranged in age from 10 to 13 years (M= 11.2 
years, SD = 1.17). Age, sex, and diagnostic status of each of the six participants are 
provided in Table 1. Five participants were Hispanic and one participant was African-
American. The mean age, ethnic distribution, and gender distribution of participants in 
this study were comparable to those in the larger CBT trial.  Three met criteria for a 
primary diagnosis of SOP, and three met criteria for a primary diagnosis of SAD. One 
child met criteria for a secondary diagnosis of ADHD, was on a stable dose of medication 
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prior to study entry and remained on a stable dose of medication through the end of the 
study. 
1.2. Measures 
1.2.1. Diagnosis and severity/impairment rating. Anxiety Disorders Interview 
Schedule for DSM-IV: Child and Parent Versions(ADIS-C/P; W. K. Silverman & A. 
M. Albano, 1996). Carefully trained evaluators administered the ADIS-C/P to each child 
and mother to assess current anxiety and related disorders in the child. Before conducting 
interviews, evaluators met a 100% reliability criterion on five video-taped child-parent 
assessments. The ADIS-C/P contains 0- to 8-point clinician severity rating (CSR) scales 
to assess the severity and interference of diagnosis. Interviewers assigned diagnoses that 
child and mother agreed were most interfering. In cases of disagreement, the interviewer 
considered both informants’ views to derive a final diagnosis. In cases of multiple 
diagnoses, the relative interference of each disorder was determined by obtaining 
interference ratings from each source and prioritizing each disorder from most to least 
interfering or disturbing. The disorder deemed most interfering or disturbing was viewed 
as primary. In the present study, CSR ratings based on interviews with mothers and 
children were used separately to examine severity and interference at pre and post. 
Research supports the CSR’s reliability (Silverman & Eisen, 1992; Silverman & Nelles, 
1988) and its sensitivity to change following treatment (Mendlowitz et al., 1999; 
Silverman et al., 1999). 
1.2.2. Measures completed by youth. 
1.2.2.1.Multidimensional Anxiety Scale for Children(MASC; March, Parker, 
Sullivan, Stallings, & Conners, 1997).The MASC is a youth self rating scale of child 
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anxiety symptoms. It contains 39 items distributed across four factors aligned with DSM-
IV diagnostic categories for anxiety disorders: Physical Symptoms, Social Anxiety, Harm 
Avoidance, and Separation Anxiety. Ratings are made on a four-point Likert scale (1 = 
never, 2 = rarely, 3 = sometimes, 4 = often). Test-retest reliability is satisfactory to 
excellent (intra-class correlations > .87). The factor structure has been supported(March 
et al., 1997) and convergent validity has been established via significant associations with 
other anxiety measures (Baldwin & Dadds, 2007).  
1.2.2.2.Revised Children’s Manifest Anxiety Scale Child version (RCMAS - C; 
Reynolds & Richmond, 1978).The RCMAS is a 37-item self-rating scale designed to 
assess child anxiety symptoms. Twenty-eight items are summed to yield a Total Anxiety 
score. Each item is rated yes or no and scored 1 or 0.Pela and Reynolds (1982) reported a 
three-week test–retest reliability of .98 for the Total Anxiety scale.  
1.2.2.3.Children’s Depression Inventory(CDI; Kovacs, 1985). The CDI is a 
widely used 27-item measure of depressive symptoms. Each item contains three choices, 
and children select the one that best describes them during the previous two weeks. The 
CDI possesses good internal consistency, and convergent validity has been demonstrated 
via significant correlations with clinician rated measures of depressive symptoms and 
other self-rated depression scales (Brooks & Kutcher, 2001; Klein, Dougherty, & Olino, 
2005; Shain, Naylor, & Alessi, 1990).  
1.2.2.4.Attention Bias to Threatening Stimuli. The attention dot-probe task 
developed by MacLeod, Matthews,& Tata (1986), modified for use in child anxiety 
studies (TAU-NIMH ABMT initiative; http://tau.ac.il/~yair1/ABMT.html), was used to 
obtain a performance-based measure of attentional bias towards threatening stimuli. 
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Facial stimuli selected for this task had been used in previous studies (Bar-Haim, Morag, 
& Glickman, 2011; Eldar et al., 2012). During the task, children were presented with 
120trials. In each trial, a white fixation cross appeared for 500 milliseconds (ms) in the 
center of the screen, followed by a pair of faces (chromatic) appearing for 500 ms. The 
pair of faces (of the same actor showing a neutral or threatening expression) appeared on 
the top and bottom of the screen. In each trial, the pair of faces displayed was one of three 
combinations (neutral-anger, anger-neutral, or neutral-neutral). Immediately following 
the faces, a probe (“<” or “>”) appeared in the location of either the top or bottom face. 
Participants were instructed to indicate the orientation of the probe by clicking the left or 
right mouse button (left for “<”, right for “>”) using their dominant hand.  The probe 
remained on-screen until the participant responded, and then the next trial began 
immediately. Angry-face location, probe location, probe type, and actor were fully 
counterbalanced in presentation. Reaction time differences of incongruent minus 
congruent trials provided a measure of attention bias, such that positive values indicated 
bias toward angry faces and negative values indicated bias away from angry faces. 
Inaccurate responses, trials with response latencies <150 ms and >1200 ms, and trials 
with response latencies+/- 2.5 SDs from the subject’s mean were excluded.   
1.2.3. Measures completed by parents. 
1.2.3.1. Revised Children’s Manifest Anxiety Scale Parent version(RCMAS - P; 
Reynolds & Richmond, 1978).In the RCMAS-P, the wording of RCMAS items was 
changed from I to my child, as done in past research (e.g., Kendall, 1994; Silverman et 
al., 1999; Silverman et al., 2009). Each item is rated either yes or no and scored 1 or 0. 
Twenty-eight items are summed to yield a Total Anxiety score.  
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1.2.3.2.Child Behavior Checklist Anxious/Depressed Subscale(CBCL; 
Achenbach & Rescorla, 2001). The CBCL contains 118 parent rated items to assess 
specific child behavioral and emotional problems. These items are rated by parents on a 
3-point scale (0 = not true; 1 = somewhat or sometimes true; 2 = very true or often true).  
The CBCL includes two broadband scales (i.e., Externalizing, Internalizing) and eight 
narrowband subscales. In the present study, we examined dimensional T-scores on the 
Anxious/Depressed narrowband subscale because, relative to other scales on the CBCL, 
it has shown a high correlation with the severity of anxiety disorders (Aschenbrand, 
Angelosante, & Kendall, 2005). 
1.3. Procedures 
 This study was conducted as approved by the Institutional Review Board. Parents 
provided informed consent and children provided assent. Assessments and training 
sessions were conducted by graduate students who had been thoroughly trained in the 
study’s procedures. 
1.3.1. Attention bias modification training. The ABMT task was identical to the 
attention bias assessment task but with three exceptions. First, a unique set of faces was 
used in this task (i.e., different from those used in the attention bias assessment task). 
Second, the task consisted of 160 trials: 120 angry-neutral presentations and 40 neutral-
neutral presentations. Third, the probe replaced the neutral face on 100% of the trials. 
Threat face location (top or bottom) and actor were fully counterbalanced. Probe type (< 
or >) was not factorially counterbalanced but appeared with equal probability for each of 
the following: angry-face location, probe location, or actor. On 75% of these trials, the 
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location of the threat face predicted the location of the probe (behind neutral); on the 
other 25%, subjects saw neutral-neutral face pairs.  
2. Results 
Pretreatment and posttreatment scores on all measures for each of the six 
participants are provided in Table 1. All six patients completed the study protocol, 
including a pre-treatment assessment, eight ABMT training sessions, and a posttreatment 
assessment within one week of the final training session. None of the families missed or 
cancelled a session. This perfect attendance record was corroborated by patients’ and 
parents’ anecdotal reports of very high satisfaction with the short duration of each 
treatment session (15 minutes) and the short course of treatment (four weeks). 
2.1. Severity Ratings for DSM-IV Anxiety Disorder Diagnoses 
 As shown in Table 1, four of the six child participants rated their primary anxiety 
disorder diagnoses as clinically interfering (≥ 4) at pre assessment, whereas only one 
participant rated her diagnosis in the clinical range (< 4) at post. Mean child self ratings 
on severity/interference (0-8) decreased from pre (M = 4.33) to post (M =2.33). In a 
paired samples t-test, this change was not statistically significant, t(5) = 1.73, p = 0.14.  
All parent severity/interference ratings were in the clinical range at pre (≥ 4), 
whereas half of parents’ severity/interference ratings were in the clinical range (< 4) at 
post. Mean parent ratings on severity/interference significantly decreased from pre (5.67) 
to post (3.50),t(5) = 3.08, p = 0.03.   
2.2. Child Rated Symptoms  
 As shown in Table 1, child self ratings on the MASC decreased from pre to post 
for all participants, and child self ratings on the RCMAS-C decreased from pre to post for 
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all participants except Participant 6. A pre-post paired samples t-test on mean MASC 
scores revealed a significant decrease from pre (M = 42.17) to post (M = 33.17),t(5)= 
3.58, p = 0.02. Similarly, mean scores on the RCMAS-C significantly decreased from pre 
(M = 5.83) to post (M = 2.50), t(5) = 3.26, p = 0.02.  
Child self ratings on the CDI decreased from pre to post for all participants except 
Participant 6. Statistically significant pre (M = 4.67) to post (M = 0.83) decreases on 
mean CDI scores were observed, t(5) = 4.39, p = 0.01.   
2.3. Parent Rated Child Symptoms 
Parent ratings on the RCMAS-P decreased from pre to post for all participants except 
Participant 6 (Table 1). Mean scores on the RCMAS-P decreased from pre (M= 11.60) to 
post (M= 8.40);this difference was not statistically significant, t(5) = 1.612, p = 
0.18.Similarly, CBCL-Anxious Depressed scores decreased from pre to post for all 
participants except Participant 1 and Participant 6 (Table 1). The decrease in mean T-
scores of the CBCL Anxious-Depressed subscale from pre (M = 62.67) to post (M = 
58.83) was not statistically significant, t(5) = 1.93, p = 0.11.  
2.4. Attention Bias to Threatening Stimuli 
Mean attention bias scores decreased from pre (M = 27.00) to post(M = 8.40), but 
this change was not statistically significant, t(4) = 0.246, p = 0.82. Although the mean 
attention bias score at pre was positive, indicating a bias toward threat on average, three 
of the six participants displayed a negative attention bias score at pre, indicating a bias 
away from threat. Attention bias scores decreased substantially from pre to post for 
Participant 1 (pre = 195, post = -117), increased modestly for Participants 2, 3, and 4 (M 
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increase = 33.00), and increased substantially for Participant 6 (pre = 10, post = 129). The 
pre attention bias score for Participant 5 was missing due to a data collection error. 
3. Discussion 
The purpose of this case series was to examine preliminarily the feasibility and 
promise of ABMT as an adjuvant treatment for children who continued to meet 
diagnostic criteria for a primary anxiety disorder following a full course of CBT. Ten 
eligible children were identified; we were able to establish contact with the families of 
eight of these children. Of these eight families, six agreed to attend the clinic twice 
weekly for ABMT sessions. All six families completed the eight sessions of ABMT over 
four weeks with no cancellations. These findings support the feasibility of ABMT as an 
adjunct for children with anxiety disorders who do not respond to a full course of CBT. 
With regard to anxiety reduction effects, ABMT led to significant mean 
reductions of anxiety symptoms on child self-report anxiety measures (MASC, RCMAS-
C). Further, mean parent report of disorder interference decreased significantly from 
pretreatment to posttreatment. Reductions in parent report of children’s anxiety 
symptoms also were observed from pretreatment to posttreatment, but were not 
statistically significant.  A statistically significant reduction in mean levels of child self 
report depressive symptoms also was found, suggesting the effects of ABMT may not be 
specific to anxiety but rather impact emotional distress in general. Similar conclusions 
have been drawn in prior studies of ABMT among children (Rozenman et al., 2011) and 
adults (Hazen, Vasey, & Schmidt, 2009).  
Findings regarding the statistical significance of effects, including discrepancies 
between the statistical significance of child self-ratings and parent ratings, should be 
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interpreted with caution given the small sample size. Although discrepancies between 
child self-ratings and parent ratings are common in the child anxiety literature (Silverman 
& Ollendick, 2005), all anxiety reduction effects, even those that were not statistically 
significant, were in the expected direction regardless of informant source. Findings 
regarding the clinical significance of effects were generally supportive of ABMT’s 
promise as an adjuvant treatment. Parent ratings of interference remained in the clinical 
range at posttreatment for half the sample, which suggests eight sessions of ABMT may 
be sufficient for some but not all children who do not respond to CBT. If this finding is 
replicated in larger trials, it will be important to investigate whether additional sessions of 
ABMT or CBT, or a switch to a different treatment modality (e.g., pharmacotherapy), 
may lead to higher response rates. 
Mean attention bias scores showed a nonsignificant decrease from pretreatment to 
posttreatment, suggesting participants’ attention was trained away from threat on average. 
Three participants displayed a bias toward threat at the pre assessment, and the other 
three participants displayed a bias away from threat. As in the multiple baseline study by 
Cowart and Ollendick (2011), some children displaying attention biases away from threat 
at pretreatment exhibited pre to post decreases in anxiety. Future studies with larger 
samples are needed to address whether treatment response differs as a function of 
pretreatment attention bias scores. 
On the level of individual cases, pre to post decreases in most child report and 
parent report measures were observed for five of the six participants. The sixth 
participant evidenced pre to post decreases in anxiety severity/interference ratings, but 
generally did not show pre to post changes on symptom measures. This was due in part to 
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scores of zero on two child report measures at pre, although a similar pattern of no pre to 
post change was observed for parent ratings on child anxiety symptoms. It is interesting 
to note the sixth participant was the only participant to evidence a large increase in 
attention bias scores from pre to post. The other four participants with available data 
evidenced either a substantial decrease in attention bias (Participant 1) or modest increase 
in attention bias from pre to post (Participants 2-4). 
The findings of this case series are generally consistent with those of previous 
studies on ABMT in clinic referred children and adolescents with anxiety disorders 
(Eldar et al., 2012; Rozenman et al., 2011) and extend the use of ABMT to anxiety 
disordered children who do not respond well to CBT. Nevertheless, the findings should 
be interpreted in light of the study’s limitations. As with most case series, the absence of 
a control group and the small sample size prevent conclusions about the efficacy of 
ABMT for CBT nonresponders. Similarly, the absence of follow-up data prevents 
conclusions regarding the maintenance of ABMT’s effects over time. Future trials of 
ABMT as an adjuvant treatment should include follow-up assessments. 
In summary, the current case series provides initial data to support the feasibility 
of ABMT as an adjuvant treatment option for children with anxiety disorders who do not 
respond well to CBT. The findings of this case series also suggest ABMT has promise in 
reducing anxiety symptoms and related impairment among children with anxiety who do 
not respond to CBT. Future research is encouraged to examine the efficacy of ABMT as a 
CBT augmentation strategy in larger samples using a randomized controlled design. 
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Table 1. Demographics and Measure Scores for 6 CBT Non-Responders Undergoing ABMT. 
Subject 
# 
Gende
r 
Age DSM-IV-
TR 
Diagnosis 
 ADIS-C/P 
Severity/Impairment 
Ratings 
MASC RCMAS-
C 
RCMAS-
P 
CBCL  
Anxious/Depresse
d T-Score 
CDI 
     Parent Child      
1 F 10 SAD Pre 4 6 41 6 3 56 6 
    Post 2 0 28 0 1 58 0 
2 M 11 SAD Pre 5 5 54 12 14 64 8 
    Post 3 6 53 6 12 59 3 
3 F 13 SAD Pre 4 3 27 9 11 77 5 
    Post 5 2 13 5 10 65 1 
4 M 10 SOP Pre 6 5 42 3 16 65 3 
    Post 2 0 33 0 5 62 0 
5 F 11 SOP Pre 7 3 54 5 9 75 6 
    Post 4 3 52 4 7 70 1 
6 F 12 SOP Pre 8 4 35 0 8 39 0 
    Post 5 3 20 0 8 39 0 
 
Note: SAD: Separation Anxiety Disorder; SOP: Social Phobia; ADIS-C/P: Anxiety Disorders Interview Schedule 
(Child/Parent versions); MASC: Multidimensional Anxiety Scale for Children; RCMAS: Revised Children’s Manifest Anxiety 
Scale (Child/Parent versions); CBCL: Child Behavior Checklist; CDI: Children’s Depression Inventory. 
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Abstract  
Objective: Attention Bias Modification Training (ABMT) for anxiety aims to train 
attention away from threatening stimuli and toward neutral stimuli. Although ABMT 
shows promising anxiety reduction effects in children and adolescents, no study has 
examined its influence on neural indicators of attention measured using event-related 
potentials (ERPs) in children or adolescents (i.e., youths). The present study examined 
the influence of ABMT on the P1, N170, P2 and P3 ERP components during completion 
of the emotional faces dot probe task in youths with anxiety disorders who failed to 
respond to cognitive behavioral therapy. Method: Thirty youths (16 females, M age = 
11.97, SD = 2.89) with primary DSM-IV-TR anxiety disorders completed the dot probe 
task while undergoing electroencephalogram (EEG) to obtain ERPs before, immediately 
after, and eight weeks after eight sessions of either ABMT (n = 14) or a control task 
regimen (CT), (n = 16). Results: At post-treatment, statistically significant effects were 
found for P1 and P3 mean amplitudes: P1 was significantly higher during trials showing 
neutral-neutral (NN) face pairs in the ABMT arm than in the CT arm; P3 was 
significantly higher during trials showing NN face pairs than during trials showing 
neutral-threat (NT) face pairs in the ABMT arm, but not the CT arm. At eight-week 
follow-up, participants in both arms showed significantly higher (more negative) N170 
responses for NN trials than for NT trials. Conclusions: Attention Bias Modification 
Treatment led to increases in neural processing of neutral stimuli in early and late stage 
attentional processing, as measured by the P1 and P3 components, respectively. These 
components during the dot probe task are promising neural markers of ABMT’s effects 
on attentional processing in youth with anxiety disorders.  
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Keywords: Attention bias, Attention Bias Modification Treatment (ABMT), Event-
related potential, anxiety, youth. Abbreviations: DSM-IV-TR: Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition, Text Revision; ADIS for DSM-IV: C/P: 
Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions; 
SCARED-C/P: Screen for Child Anxiety & Related Disorders, Child & Parent Versions; 
PARS: Pediatric Anxiety Rating Scale; ERPs: event-related potentials; EEG: 
electroencephalogram.  
Introduction 
Anxiety disorders are among the most prevalent psychiatric disorders in children 
and adolescents (i.e., youths; Costello, Egger, Copeland, Erkanli, & Angold, 2011), lead 
to substantial impairments (Silverman & Ollendick, 2005) and are associated with 
enormous mental health costs (Simon, Dirksen, Bögels, & Bodden, 2012). The leading 
evidence-based treatment for youth anxiety disorders is cognitive-behavioral therapy 
(CBT). Cognitive-behavioral therapy primarily targets “top down,” strategic cognitive 
processes such as identifying and modifying interpretations of ambiguous events and 
situations. Despite the demonstrated efficacy of CBT, up to 50% of youths continue to 
meet criteria for anxiety disorders and experience emotional distress and impairment after 
a full course of treatment (Compton et al., 2004; Rapee, Schniering, & Hudson, 2009; 
Silverman, Pina, & Viswesvaran, 2008).  Thus, youth anxiety CBT nonresponders 
represent a large and clinically challenging population. Perhaps youths who do not 
respond well to a top-down approach like CBT would alternatively respond better to an 
approach that targets bottom-up, implicit processes (Bechor et al., 2014). 
 62 
 
Cognitive theories of anxiety emphasize the role of heightened attention to threat 
as a bottom up, implicit process involved in the development and maintenance of anxiety 
disorders (Lonigan et al., 2004; Mogg & Bradley, 1998).  Heightened attention to threat, 
or attention bias to threat, has been documented in individuals with anxiety disorders, 
including youths (Bar-Haim et al., 2007; Dudeney et al., 2015). The translational 
treatment implication of heightened attention to threat is attention bias modification 
training (ABMT). This dissertation study presents findings on the influence of ABMT on 
neural markers (event-related potential components) of attention to threat at immediate 
posttreatment, and at a follow-up assessment eight weeks after treatment, in youth 
anxiety CBT nonresponders.  
Neural Markers of Attention to Threat 
Anxiety is notable for its marked cross-species conservation of brain-behavior 
associations; changes in neural network engagement and information processing occur 
when an organism confronts a threat (Pine, 2009). These associations and changes have 
been shown in referred and nonreferred youths and adults (Lindstrom et al., 2009), 
suggesting developmental continuity in the neural processes underlying response to 
threat. To identify the neural correlates of attention processes, including attention bias to 
threat, past research has examined event-related potentials (ERPs) time-locked to the 
onset of the visual stimuli presented in an emotional faces dot probe task (Bar-Haim et 
al., 2005; Eldar & Bar-Haim, 2010; Luck, 2005; Thai et al., 2016). ERPs refer to the 
electrophysiological response to a sensory, cognitive or motor stimulus (Luck, 2005; in 
this instance, threatening and/or neutral stimuli) and can be used to track the time course 
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or chronometry of neural activity involved in threat processing (Heeren, De Raedt, 
Koster, & Philippot, 2013; O’Toole & Dennis, 2012; Suway et al., 2013).  
Past research provides evidence linking four ERP components to the neural 
chronometry of attention bias to threat: P1, N170, P2 and P3 amplitudes in youths 
(Bechor et al., unpublished manuscript; O'Toole et al., 2013) . P1, which represents 
attention orienting to visual stimuli (Hillyard et al., 1996), has been associated with 
sensory processing of emotional faces (Lang, Bradley, & Cuthbert, 1998). The N170 is a 
negative deflection component that is related to early processing of and discrimination of 
facial structures or formations; the N170 can be regarded as an index of selection and 
discrimination of faces (Balconi & Lucchiari, 2005; Batty & Taylor, 2003; Eimer, 2000; 
Wronka & Walentowska, 2011). The P2 component represents a neural response to 
threatening stimuli in the dot probe assessment task (O’Toole & Dennis, 2012). The P3 
component represents later-stage, strategic attention processing (Eldar & Bar-Haim, 
2010; Heeren et al., 2013), and has been linked to extended stimulus evaluation and 
cognitive processes like response selection ( Falkenstein, Hohnsbein, & Hoormann, 1994; 
Verleger, 1997). These four ERP components (i.e., P1, N170, P2, P3) thus represent 
potential neural markers of attention to threat.  
Influence of Attention Training on Neural Markers of Attention to Threat 
As noted, ABMT is the translational treatment implication of attention bias to 
threat (Eldar et al., 2012; Yuko Hakamata et al., 2010). Attention Bias Modification 
Treatment aims to shape attention bias via repetitive, computer-based training. In ABMT, 
participants complete hundreds of trials of a modified dot probe task in which the probe 
always replaces a neutral stimulus and never replaces a threatening stimulus (Bar-Haim, 
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2010; Bechor et al., 2014). Over repeated trials, this establishes a contingency between 
neutral face and probe location, leading to increased attention to neutral stimuli and 
reduced attention to threatening stimuli (Yair Bar-Haim, 2010; Suway et al., 2013). 
ABMT has shown promising anxiety reduction effects in nonreferred (Bar-Haim et al., 
2005; Eldar, Ricon, & Bar-Haim, 2008) and referred youths (Bechor et al., 2014; Cowart 
& Ollendick, 2011; Eldar et al., 2012; Pergamin-Hight, Naim, Bakermans-Kranenburg, 
van, & Bar-Haim, 2015; Pettit et al., 2017; Rozenman et al., 2011).  
Reduction in neural processes subserving attention bias to threat has been 
theorized as the mediator of ABMT (O’Toole & Dennis, 2012). However, whether 
ABMT produces changes in underlying neural processes, or is mediated by changes in 
such processes, remains unknown (Bar-Haim, 2010; Hakamata et al., 2010; Heeren et al., 
2013). This is an important gap in the literature because it remains unclear how ABMT 
leads to reductions in anxiety. Further, multiple studies have found anxiety reduction 
effects following an attention control task regimen that is identical to ABMT with the 
exception that the probe replaces the neutral stimulus and the threatening stimulus with 
equal probability (i.e., there is no training contingency; Pergamin‐Hight, Pine, Fox, & 
Bar‐Haim, 2016). This anxiety-reduction effect has provoked calls for research into 
which components of attention processing are influenced by ABMT as well as the control 
task (Mogg, Waters, & Bradley, 2017). Findings that shed light on which ERP 
components change in response to ABMT and the control task in youth may guide future 
treatment outcome research and investigation into which components of attention training 
yield maximal anxiety symptom reduction. 
 65 
 
The current study responds to these calls and addresses this important gap in the 
literature by collecting ERP data at the pretreatment, posttreatment, and eight-week 
follow-up assessments in a randomized controlled trial of ABMT in youths with anxiety 
disorders who did not respond to CBT. ERP data provide precise information about 
where in neural information processing stream attention training exerts its effects (Suway 
et al., 2013). This ERP data may provide insight into which ERP components are 
associated with anxiety reduction effects and also be used to refine and streamline 
attention training programs to target specific neural markers at specific time points 
(Cuthbert, 2014; Cuthbert & Insel, 2013). 
The influence of ABMT on neural markers of attention to threat, as measured via 
ERPs, has never been studied in youths. Past research in nonreferred samples of adults 
suggests that the P1, N170, P2 and P3 components during the dot probe task may be 
sensitive to attention training. For example, studies in samples of non-referred adults 
found that attention training away from threat, as is used in ABMT, led to decreases in 
the P1 (Dennis-Tiwary, Egan, Babkirk, & Denefrio, 2016; O’Toole & Dennis, 2012), P2, 
and P3 amplitudes (Eldar & Bar-Haim, 2010), and increases (i.e., potentiation) in the 
N170 amplitude (Dennis-Tiwary et al., 2016) during threat trials of the dot probe task. 
Further, studies in non-referred adults found that attention training toward threat, the 
opposite approach of that used in ABMT, led to increases in the P2 and P3 amplitudes 
during threat trials of the dot probe task (Eldar & Bar-Haim, 2010; Suway et al., 2013). 
These findings support the sensitivity of these ERP components to attention training in 
adults.  
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The present study builds on these findings to examine the influence of ABMT 
versus a control task on neural markers of attention to threat in youths with anxiety 
disorders who did not respond to CBT. On the basis of the research findings reviewed 
above, I considered three hypotheses. Hypothesis 1 was that attention bias scores during 
threat trials on the dot probe task will significantly and positively correlate with higher 
P1, P2 and P3 and larger (more negative) N170 amplitudes, and with greater anxiety 
symptom severity, at pre-treatment; Hypothesis 2 was that youth in the ABMT arm will 
exhibit significantly decreased P1, P2 and P3 and stronger (more negative) N170 
amplitudes during threat trials following treatment compared to youth in the Control Task 
arm; Hypothesis 3 was that youth in the ABMT arm will continue to exhibit significantly 
decreased P1, P2 and P3 and stronger (more negative) N170 amplitudes during threat 
trials eight weeks after post-treatment compared to youth in the control arm, suggesting 
maintenance effects of ABMT.  
Method 
Participants 
Participants were recruited upon entry to an RCT of ABMT for youth with 
anxiety disorders who did not respond to CBT. All participants had completed a 12-14 
week CBT protocol (see Silverman, Kurtines, Jaccard, & Pina, 2009).Youth were eligible 
for the RCT if they were between ages seven to 18 years and met criteria for a primary 
DSM-IV (American Psychiatric Association, 2000) diagnosis of Generalized Anxiety 
Disorder (GAD), Social Phobia (SOP), or Separation Anxiety Disorder (SAD) at post-
treatment and 12-month follow-up assessments of the CBT protocol. Exclusion criteria 
were (a) meeting diagnostic criteria for Organic Mental Disorders, Psychotic Disorders, 
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Pervasive Developmental Disorders, or Mental Retardation, (b) showing high likelihood 
and/or serious intent of self-harm; (c) not living with a primary caregiver who was legally 
able to give consent for participation, (d) having a serious, uncorrected vision problem 
and (e) having a physical disability which interfered with the child’s ability to click a 
mouse button rapidly and repeatedly. Children with comorbid ADHD, minimally 
impairing tics or impulse control problems or depressive disorders were eligible, as long 
as each comorbid disorder was treated and stable.  
Upon consenting/assenting to the RCT, youth and their parents were asked to take 
part in an additional, supplemental ERP study, requiring completion of EEG 
measurement at each of three assessment points (pre-treatment, post-treatment, eight-
week follow-up).  Fifty-three candidate participants were eligible and approached; 46 
(87%) consented/assented and completed pre-treatment ERP measurement, 35 of the 46 
(76%) completed post-treatment ERP measurement, and 32 of the 35 (91%) completed 
eight-week follow-up ERP measurement. One post-treatment and one eight-week follow-
up ERP measure were discarded due to instrumentation error. Thus, N=30 youths 
completed all aspects of the protocol including pre-treatment, post-treatment, and eight-
week follow-up ERP measurements, and their diagnostic (Anxiety Disorders Interview 
Schedule for DSM-IV: Child and Parent Versions [ADIS-C/P]), behavioral (Pediatric 
Anxiety Rating Scale [PARS]; Screen for Child Anxiety & Related Disorders-Child and 
Parent versions[SCARED-C/P]; dot probe threat bias scores) and neural data (P1, N170, 
P2 & P3 mean amplitudes) were utilized in statistical analyses. Of the N=30 youths, 16 
were randomized to the Control Task (CT) arm (mean age: 11.19 years [SD = 2.87], ages 
7 to 16 years; 8 males [50%]), and N=14 were randomized to the ABMT arm (mean age: 
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12.86 years [SD = 2.77], ages 8 to 18 years; 6 males [43%]). Table 1 provides a 
breakdown of diagnoses and Pediatric Anxiety Rating Scale (PARS) total scores across 
arms. Six youths in the CT arm met diagnostic criteria for a comorbid (non-primary) 
diagnosis of Attention-Deficit Hyperactivity-Inattentive type (ADHD-I) and one met 
criteria for Attention-Deficit Hyperactivity-Combined type (ADHD-C). The distribution 
of ADHD diagnosis significantly differed across study arms, χ2(1) = 7.99, p = 0.01. Thus, 
as mentioned below, ADHD diagnosis was included as a statistical covariate in all main 
analyses. Three youths in the CT arm were on a stable dose of medication at the time of 
assessment, for attention deficits (n=2) or for anxiety (n =1); five youths in the ABMT 
arm were on a stable dose of medication at the time of assessment, for attention deficits 
(n =1) or for anxiety (n =3) and for anxiety-related medical problems (n =1); the number 
of youths on medications did not significantly differ across study arms, χ2(1) = 1.10, p = 
0.30. All procedures were approved by the appropriate Institutional Review Board.  
Measures 
Diagnostic measure.  
Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions 
(ADIS-IV:C/P.) The ADIS-IV: C/P (Albano & Silverman, 1996)  is a semi-structured 
interview designed to assess anxiety and related disorders in youth. Carefully trained 
evaluators administered the ADIS-C/P to each youth and parent; diagnoses were given 
when one or both informants met diagnostic criteria. Before conducting interviews, 
evaluators met a 100% reliability criterion on five videotaped child-parent assessments. 
The ADIS-IV: C/P yields retest reliability kappas between .80 to .92 for diagnoses and 
significant associations with youth anxiety ratings (e.g., Silverman et al., 2001). 
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Anxiety severity ratings.  
Pediatric Anxiety Rating Scale (PARS . Independent Evaluator (IE) rated anxiety 
severity was measured at pre-treatment, post-treatment and eight-week follow-up. The 
PARS (RUPP Anxiety Study Group, 2002) assesses global anxiety severity across SOP, 
SAD, and GAD in youth ages 6-17. Using information obtained from interviews with 
parents and youths, an IE scores each of 50 anxiety symptoms as present or absent during 
the past week. Endorsed symptoms are rated by the IE on seven dimensions. Each 
dimension is rated from zero to five; total scores range from 0-35, with higher scores 
indicating more anxiety. Before conducting interviews, IEs met a 80% reliability criterion 
on five audiotaped child-parent assessments. The PARS has adequate internal 
consistency (αs .64-.91) and interrater reliability (intra-class correlations .78-.97), 
sensitivity to change in treatment studies, and convergent validity (Mogg & Bradley, 
1999; RUPP Anxiety Study Group, 2002). In this sample, the alpha coefficient was .90. 
Screen for Child Anxiety & Related Disorders-Child version (SCARED-C; 
Birmaher et al., 1999; Birmaher et al., 1997). The SCARED-C consists of 41 items on 
which youth rate their anxiety symptoms on a three-point scale. Test-retest reliability is 
satisfactory to excellent (ranging from .70 to .90). The SCARED-C has demonstrated 
good convergent and divergent validity compared with other widely used screening 
scales (Birmaher et al., 1999; Birmaher et al., 1997). In this sample, the alpha coefficient 
was .91. 
Screen for Child Anxiety & Related Disorders- Parent version (SCARED-P; 
Birmaher et al., 1999; Birmaher et al., 1997). The SCARED-P consists of 41 items on 
which parents rate youth anxiety symptoms on a three-point scale. The reliability and 
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validity of the SCARED-P have been demonstrated repeatedly and mirror those of the 
SCARED-C (Birmaher et al., 1999; Birmaher et al., 1997). In this sample, the alpha 
coefficient was .96. 
 Dot probe task. 
 Behavioral assessment. The emotional faces dot probe task developed by 
MacLeod, Mathews & Tata (1986), modified for use in child anxiety studies (TAU-
NIMH ABMT initiative; http://people.socsci.tau.ac.il/mu/anxietytrauma/tau-nimh-abmt-
initiative-participating/), was used to obtain a behavioral measure of attentional bias 
towards threatening stimuli.  
In each trial, a white fixation cross appeared for 500 milliseconds (ms) in the 
center of the screen, followed by a pair of faces (chromatic) appearing for 500 ms. The 
pair of faces of the same actor showing a neutral or angry (i.e., threatening) expression 
appeared on the top and bottom of the screen. In each trial, the pair of faces displayed 
was one of three combinations (80 neutral-angry, 80 angry-neutral, or 80 neutral-neutral) 
for a total of 160 neutral-threat (NT) trials and 80 neutral-neutral (NN) trials. 
Immediately following the faces, a probe (“<” or “>”) appeared in the location of either 
the top or bottom face. Participants were instructed to indicate the orientation of the 
probe by clicking the left or right mouse button (left for “<”, right for “>”) using their 
dominant hand. The probe remained on-screen until the participant responded or for 1000 
ms. A response was followed by an inter-trial interval (500 ms), and then the next trial 
began immediately. Angry-face location, probe location, probe type, and actor were fully 
counterbalanced in presentation. The importance of completing the task as quickly as 
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possible without compromising accuracy was emphasized. Trials were presented using E-
Prime software (Psychology Software Tools, Pittsburgh, PA).  
Responses on the dot probe behavioral assessment task were used to calculate 
mean reaction times (RT) on trials, total number of accurate trials, and attention bias 
scores. Trials in which the probe replaced angry face were considered congruent trials, 
and trials in which the probe replaced the neutral face were considered incongruent trials. 
Bias scores were computed as reaction time differences of incongruent minus congruent 
trials. Positive attention bias scores indicate a bias toward angry faces (i.e., threat) and 
negative values indicate a bias away from threat. Inaccurate responses, trials with 
response latencies <150 ms and >1200 ms, and trials with response latencies +/- 2.5 SDs 
from the participant’s mean were excluded (e.g., Eldar et al., 2010).   
ABMT or CT task. As part of the randomized treatment protocol of the RCT, 
each participant completed eight sessions of either the ABMT task or the CT task. The 
ABMT task was identical to the dot probe behavioral assessment task but with three 
exceptions. First, a unique set of faces was used in this task (i.e., different from those 
used in the dot probe behavioral assessment task). Second, the task consisted of 160 
trials: 120 angry-neutral presentations and 40 neutral-neutral presentations. Third, the 
probe replaced the neutral face on 100% of the trials. Threat face location (top or bottom) 
and actor were fully counterbalanced. Across the entire task, on 75% of the trials, the 
location of the threat face predicted the location of the probe (behind neutral); on the 
other 25%, subjects saw neutral-neutral face pairs.  
The CT task was identical to the dot probe behavioral assessment task with two 
exceptions. First, a unique set of faces was used in this task (i.e., different from those 
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used in the dot probe behavioral assessment task). Second, the task consisted of 160 
trials: 120 angry-neutral presentations and 40 neutral-neutral presentations. In the CT 
task, the probe replaced the neutral face on 50% of trials and replaced the threat face on 
50% of trials. 
 Electrophysiological recording. Each participant was fitted with a 64-electrode 
elasticized nylon cap (WaveGuard; Advanced Neuro Technology, Enschede, 
Netherlands) with sewn-in Ag/AgCl shielded electrodes following the international 10-20 
electrode system. The raw signal was amplified by 25,000 using a high-input impedance 
AsaLab amplifier (Advanced Neuro Technology, Enschede, Netherlands). The EEG data 
was sampled at 1024 Hz with a high-pass filter of .3 Hz. Data acquisition began once 
impedance values were below 50 kΩ (a resistance level used for studies in comparable 
age ranges; Thai et al., 2016). During recording, ERPs were referenced to CPz. AFz 
served as the ground electrode. The EEG data were further analyzed offline using 
EEGLab (Delorme & Makeig, 2004) and ERPLab (Lopez-Calderon & Luck, 2014) 
software. EEG data were collected at three time points: pre-assessment, post-assessment 
and eight-week follow-up assessment. EEG data were not collected during the training 
sessions (CT or ABMT).  
 Event Related Potentials. In post-processing, EEG data were re-referenced to 
average reference and re-filtered with a low-pass filter of 30 Hz. Data were baseline-
corrected to the average voltage during the 100 ms prior to stimulus onset (i.e., onset of 
facial pair stimuli). Data were resampled offline at 512 Hz. Ocular and motor artifacts 
exceeding ±75 mV were rejected. Data were segmented and visually inspected for 
additional ocular and motion artifact. Epochs containing blink activity were removed as 
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electrooculogram (EOG) contamination. Trials consisted of a 100 ms baseline period and 
500 ms period following onset of facial stimuli.   
 Stimulus-Evoked ERP Components. Specific components of interest were P1, 
P2, P3 and N170. In line with previous studies, P1, P2, P3 and N170 components were 
examined at midline parieto-occipital sites (Oz and POz; Batty & Taylor, 2006; Eldar et 
al., 2010; Mühlberger et al., 2009; O'Toole et al., 2013; Segalowitz et al., 2010). Each 
participant’s grand average waveforms were visually inspected to determine the window 
in which the maximal peak of each proposed component was found. Exhaustive windows 
were shaped by minima and maxima of peak onset ranges recorded per participant, and 
group-wise grand averages were inspected for each component to confirm the latency 
windows included all participants’ components. Non-overlapping latency windows for P1 
(100-160 ms), N170 (170-230 ms), P2 (230-280 ms), and P3 (300-380 ms) were 
generated separately in ERPLAB and individual mean amplitudes and peak latencies for 
each component were imported into the statistical software program SPSS version 22.0 
(SPSS, 2013) for statistical analysis.  
Statistical Analysis  
Independent samples t-tests were used to examine group differences (i.e., across 
study arms) on age, PARS total scores, dot probe behavioral assessment reaction time 
(RT) scores and SCARED-C/P scores; a chi-square analysis was used to examine gender 
distribution across arms. Youths in the CT arm were significantly more likely to meet 
diagnostic criteria for ADHD than youths in the ABMT arm, so ADHD diagnosis was 
included as a covariate in all statistical analyses. Variables considered in these between-
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group analyses were anxiety level (PARS; SCARED-C/P), attention bias (AB) score (dot 
probe task), and P1, N170, P2 and P3 mean amplitudes at POz and Oz. 
Initial ERP analyses employed a 3 x 2 x 2 x 2 repeated measures Analysis of 
Covariance (ANCOVA) with time point (pre-treatment, post-treatment, eight-week 
follow-up), site (POz, Oz) and stimulus (trial type: NT or NN) as within-subjects factors, 
arm (CT or ABMT) as a between-subjects factor, and age, current medication status and 
comorbid ADHD diagnosis as covariates. Because the study population included a 
relatively large age range (eight to 18 years), age was also included as a covariate in all 
analyses. Medication usage was included as a covariate in all analyses because of its 
potential effects on anxiety and attention symptoms. Preliminary analyses found a 
significant main effect of site for each component (P1: F[1,25] = 53.84, p < .001, ηp2 = 
.68; N170: F[1,25] = 25.12, p < .001, ηp2 = .501; P2: F[1,25] = 11.41, p = .002, ηp2 = .31; 
P3:  F[1,25] = 17.33 p < .001, ηp2 = .41); therefore, all subsequent analyses examined 
effects at Oz and POz separately. 
To examine the associations between behavioral and neural measures of attention 
bias at a pre- and again at post-treatment assessment, I calculated Pearson’s correlations 
between the attention bias score and each of the P1, N170, P2 and P3 amplitudes in 
response to threatening or neutral stimuli. To examine the associations between neural 
measures of attention bias and anxiety symptoms, I calculated Pearson’s correlations 
between (a) scores on the SCARED-C/P and PARS and each of the P1, N170, P2 and P3 
components’ mean amplitude and (b) scores on the dot probe behavioral assessment task 
and each of the P1, N170, P2 and P3 components’ mean amplitude.  
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To examine differences in mean amplitudes as a function of study arm, I 
subjected each ERP component (P1, N170, P2 and P3) to a 2 x 2 repeated measures 
ANCOVA with stimulus (trial type: NT or NN) as within-subjects factor and arm (CT or 
ABMT) as between-subjects factor, and age, current medication status, and comorbid 
ADHD diagnosis as covariates at immediate post-treatment. I also included pre-treatment 
scores (NT & NN mean amplitudes) as covariates to increase statistical power as well as 
control for any potential group differences observed in pre-treatment measures. Post-hoc 
analyses examined significant stimulus type by arm interaction effects and main effects 
of arm or stimulus type.  
 To examine maintenance effects, I used the same analytic approach as described 
in the preceding paragraph, using eight-week follow-up scores as the outcome variables 
and pre-treatment scores (NT & NN mean amplitudes) and post-treatment scores (NT and 
NN mean amplitudes) as covariates to increase statistical power.   
Results 
Attention to Threat and Anxiety Severity Ratings 
Age and gender did not significantly differ for CT (M =11.19, SD = 2.86) and 
ABMT (M =12.86, SD = 2.77) arms (age: t(28) = -1.62, p = .12, d = 0.59; gender: χ2(1) = 
0.15, p = .70). Mean RTs, accuracy scores and threat bias scores on the dot probe task 
and mean scores on the PARS and SCARED-C/P are presented in Table 1. Mean scores 
on the SCARED-C/P, PARS, threat bias scores, and dot probe task mean RTs or accuracy 
did not significantly differ between study arms at pre-treatment, post-treatment or eight-
week follow-up (ps >.08).  
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Electrophysiological Data 
 Mean number of epochs remaining after artifact rejection (NT + NN) at pre-
treatment did not differ significantly between CT (M =148.44, SD = 57.40) and ABMT 
(M =173.57, SD = 25.52) arms, t(21.29) = -1.58, p = .13, d = 0.57. At post-treatment, 
youths in the CT arm had fewer total number of epochs (M =145.81, SD = 53.31) than 
youths in the ABMT arm (M =181.79, SD = 26.35), t(22.52) = -2.39, p = .03, d = 0.86. At 
eight-week follow-up, youths in the CT arm had fewer total number of epochs (M 
=148.19, SD = 52.85) than youths in the ABMT arm (M =189.71, SD = 21.94), t(20.57) = 
-2.87, p = .01, d = 1.03. As total number of epochs results from a combination of youths’ 
accuracy on trials (incorrect trials are excluded from processing) and from amount of 
ocular artifact removed from each dot probe assessment, I measured arm differences in 
accuracy at each assessment wave; differences were not statistically significant at any 
assessment wave (ps > .11). Thus, I did not include accuracy as a covariate in analyses.  
Results on the influence of ABMT on ERP amplitudes are presented in two parts. 
The first part presents results of statistical analyses as planned in the original dissertation 
proposal. The second part presents the same analyses with one critical exception: instead 
of utilizing separate amplitude measures for NT and NN trials as covariates in analyses, a 
difference score between mean amplitudes on these trials (NT-NN) was utilized as a 
covariate. As explained below, in preliminary analyses I found statistically significant 
differences in ERP amplitudes between study arms at pre-treatment. These differences 
presented challenges for interpretation of findings. The inclusion of differences scores for 
mean amplitudes (Part II) eliminated pre-treatment arm differences to facilitate 
interpretation of findings. 
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Part I: Testing Hypotheses without Adjusting for Pre-treatment Differences 
between Study Arms 
Correlations between ERP measures and behavioral data at pre-treatment. 
 My first set of hypotheses (i.e., Hypothesis 1) was that attention bias scores on the 
dot probe task will be significantly and positively correlated with higher P1, P2, and P3 
amplitudes during threat trials, larger (more negative) N170 amplitudes during threat 
trials, and greater anxiety symptom severity. All correlation coefficients relevant to 
Hypothesis 1 are presented in Table 2. At pre-treatment, attention bias (AB) scores on the 
dot probe task were not significantly correlated with P1, N170, P2 or P3 mean amplitudes 
at site POz or Oz, or with anxiety symptom severity as measured by the SCARED-P, 
SCARED-C, and PARS.  
Influence of ABMT on ERP Measures at Post-treatment. 
 My second set of hypotheses (i.e., Hypothesis 2) was that youths in the ABMT 
arm will exhibit significantly decreased P1, P2 and P3 and stronger (more negative) N170 
amplitudes during NT trials at post-treatment as compared to youths in the CT arm. 
Figure 1 presents the ERP waveforms at pre-treatment, post-treatment and eight-week 
follow-up across both arms at site POz. Figure 2 presents the waveforms at pre-treatment, 
post-treatment and eight-week follow-up across both arms at site Oz. In the following 
sections, I present findings separately for each ERP component. 
P1.  
Site POz. The stimulus type by arm interaction effect was statistically significant, 
F(1,23) = 6.95, p = .02, ηp2= .23. Post-hoc analyses revealed a marginally significant 
main effect of arm on P1 mean amplitude during NN trials, F(1,24) = 3.14, p = .09, ηp2= 
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.12; amplitudes in the ABMT arm (M = 8.39, SE = 1.49) were higher than in the CT arm 
(M = 4.39, SE = 1.37). The main effect of arm on P1 mean amplitude during NT trials did 
not approach significance, F(1,24) = .04, p = .85, ηp2= .00. Main effects of stimulus type 
were nonsignificant in the CT arm, F(1,10) = 1.11, p = .32, ηp2= .10, and the ABMT arm, 
F(1,9) = .89, p = .37, ηp2= .09. See Figure 3(a) for a bar graph depicting the main effect 
of arm within NN trials. 
Site Oz. The stimulus type by arm interaction effect was not statistically 
significant, F(1,23) = .98, p = .33, ηp2= .04. The main effects of arm and stimulus type 
were not statistically significant. 
N170.  
Site POz. The stimulus type by arm interaction effect was not statistically 
significant, F(1,23) = 2.32, p = .14, ηp2= .09. The main effects of arm and stimulus type 
were not statistically significant. 
Site Oz. The stimulus type by arm interaction effect was not statistically 
significant, F(1,23) = .14, p = .71, ηp2= .01. The main effects of arm and stimulus type 
were not statistically significant. 
P2.  
Site POz. The stimulus type by arm interaction effect was marginally significant, 
F(1,23) = 3.69, p = .07, ηp2= .14. Post-hoc analyses revealed a nonsignificant main effect 
of arm on P2 mean amplitude during NN trials, F(1,24) = 1.56, p = .22, ηp2= .06; 
amplitudes in the ABMT arm (M =3.74, SE = 2.66) were higher than in the CT arm (M = 
-1.47, SE = 2.44). The main effect of arm on P2 mean amplitude during NT trials did not 
approach significance, F(1,24) = .17, p = .68, ηp2= .01. Main effects of stimulus type 
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were nonsignificant in the CT arm, F(1,10) = .74, p = .41, ηp2= .07, and the ABMT arm, 
F(1,9) = .00, p = .99, ηp2= .00. 
Site Oz. The stimulus type by arm interaction effect was not statistically 
significant, F(1,23) = .69, p = .41, ηp2= .03. The main effects of arm and stimulus type 
were not statistically significant. 
P3.  
Site POz. The stimulus type by arm interaction effect was statistically significant, 
F(1,23) = 4.53, p = .04, ηp2= .16. Post-hoc analyses revealed a nonsignificant main effect 
of stimulus on P3 mean amplitude in the ABMT arm, F(1,9) = 1.98, p = .19, ηp2= .18, and 
the CT arm, F(1,10) = .80, p = .39, ηp2= .07. The main effect of arm on P3 mean 
amplitude during NT trials across groups did not approach significance, F(1,24) = .49, p 
= .49, ηp2= .02, nor did the main effect of arm on P3 mean amplitude during NN trials, 
F(1,24) = .14, p = .71, ηp2= .01. See Figure 3(b) for a bar graph depicting the significant 
stimulus-type-by-arm interaction effect for P3 mean amplitudes at post-treatment. 
Site Oz. The stimulus type by arm interaction effect was not statistically 
significant, F(1,23) = 1.50, p = .24, ηp2= .06. The main effects of arm and stimulus type 
were not statistically significant. 
Influence of ABMT on ERP Measures at Eight-week Follow-up. 
My third set of hypotheses (i.e., Hypothesis 3) was that youths in the ABMT arm 
will exhibit significantly decreased P1, P2 and P3 and stronger (more negative) N170 
amplitudes during NT trials at eight-week follow-up as compared to youths in the CT 
arm. In the following sections, I present findings separately for each ERP component. 
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P1.  
Site POz. The stimulus type by arm interaction effect was not statistically 
significant, F(1,21) = 2.88, p = .80, ηp2= .00. However, there was a significant main 
effect of arm, F(1,21) = 5.28, p = .03, ηp2= .20; collapsed across stimulus type, P1 mean 
amplitude was significantly larger in the CT arm (M = 6.63, SE = 2.22) than the ABMT 
arm, (M = -2.31, SE = 2.44). See Figure 4(a) for a bar graph of the significant main effect 
of treatment arm on P1 mean amplitudes at eight-week follow-up. The main effect of 
stimulus type was not statistically significant. 
Site Oz. The stimulus type by arm interaction effect was not statistically 
significant, F(1,21) = .11, p = .75, ηp2= .01. The main effects of arm and stimulus type 
were not statistically significant. 
N170.  
Site POz. The stimulus type by arm interaction effect was not statistically 
significant, F(1,21) = .01, p = .92, ηp2= .00. However, there was a significant main effect 
of stimulus type, F(1,21) = 6.09, p = .02, ηp2= .23; collapsed across arms, N170 mean 
amplitude was significantly larger (more negative) during NN trials (M = 2.02, SE = 
2.07) than NT trials (M = 2.70, SE = 1.01). See Figure 4(b) for a bar graph of the 
significant main effect of stimulus type within the CT group for N170 mean amplitudes at 
eight-week follow-up. The main effect of arm was not statistically significant. 
Site Oz. The stimulus type by arm interaction effect was not statistically 
significant, F(1,21) = .30, p = .59, ηp2= .01. The main effects of arm and stimulus type 
were not statistically significant. 
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P2.  
Site POz. The stimulus type by arm interaction effect was not statistically 
significant, F(1,21) = .52, p = .48, ηp2= .02. The main effects of arm and stimulus type 
were not statistically significant. 
Site Oz. The stimulus type by arm interaction effect was not statistically 
significant, F(1,21) = .09, p = .77, ηp2= .00. The main effects of arm and stimulus type 
were not statistically significant. 
P3.  
Site POz. The stimulus type by arm interaction effect was not statistically 
significant, F(1,21) = 1.59, p = .22, ηp2= .07. The main effects of arm and stimulus type 
were not statistically significant. 
Site Oz. The stimulus type by arm interaction effect was not statistically 
significant, F(1,21) = .40, p = .53, ηp2= .02. The main effects of arm and stimulus type 
were not statistically significant. 
Part II: Testing Hypotheses after Adjusting for Pre-treatment Differences between 
Study Arms 
In preliminary analyses, I found statistically significant differences in ERP 
amplitudes between the two study arms at pre-treatment: POz (N170 & P2) and Oz (P1, 
P2 and P3).  I also found statistically significant differences in ERP amplitudes between 
stimulus types at pre-treatment: POz (P1) and Oz (P1, N170). See Table 3(a) for details. 
These significant ERP differences between study arms were unexpected and occurred 
despite random assignment to conditions.  
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In order to account for significant ERP differences between study arms and 
stimulus types at pre-treatment, I computed a difference score between NT amplitudes 
and NN amplitudes (NT - NN) for each component (P1, N170, P2, P3) at both sites of 
interest (POz, Oz) at each time point (pre-treatment, post-treatment, eight-week follow-
up). A larger value for P1, P2, and P3 and a smaller value for N170 represents greater 
activation during NT trials compared to NN trials. Similarly, a greater positive difference 
score for P1, P2, or P3 reflect greater attention toward threat stimuli compared to neutral 
stimuli. In contrast, a greater negative difference score for N170 reflects greater attention 
allocated toward threat compared to neutral stimuli.  The use of the difference score 
allows for the control of significant between-group differences in amplitudes at pre-
treatment while preserving within group differences in amplitudes observed for NT and 
NN at post-treatment and two-month follow-up. See Table 3(b) which shows results of 
univariate ANCOVAs for arm effects at each time point, per component, per site; this 
table shows that calculating a NT-NN difference score yields no significant main effect 
of arm at pre-treatment. Using these difference scores, I then re-ran the same analyses as 
reported in Part I of the Results without including stimulus type as a within-subjects 
variable. See Figure 5 for NT-NN difference scores between arms at each time point at 
site POz, and see Figure 6 for such differences at site Oz. To test Hypothesis 2, I ran a 
univariate ANCOVA with post-treatment difference (NT-NN) scores as within subjects 
factor and arm (CT, ABMT) as between-subjects factor, with pre-treatment difference 
(NT-NN) scores, age, medication status, and ADHD diagnosis as covariates. To test 
Hypothesis 3, I ran the same analyses as in Hypothesis 2 but with eight-week follow-up 
difference (NT-NN) scores as within subjects factor, with both pre-treatment and post-
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treatment difference (NT-NN) scores, age, medication status, and ADHD diagnosis as 
covariates. 
Correlations between ERP measures and behavioral data at pre-treatment. 
 All Hypothesis 1 correlations utilizing difference scores (NT-NN) are listed in 
Table 4.  
Site POz. At pre-treatment, SCARED-C was significantly positively correlated 
with P2 mean amplitude difference (NT-NN) score, (r = .35, N = 34, p = .04). Relatively 
more neural activity during NT trials than during NN trials was significantly associated 
with higher levels of anxiety symptom severity (as per youth report). 
Site Oz.  At pre-treatment, attention bias (AB) score on the dot probe task was 
significantly negatively correlated with P2 mean amplitude difference (NT-NN) score (r 
= -.37, N = 32, p = .03) such that relatively more neural activity during NN trials than 
during NT trials was associated with higher levels of attention bias toward threat. 
Influence of ABMT on ERP Measures at Post-treatment. 
P1.  
Site POz. A significant main effect of arm was found at POz at post-treatment, 
F(1,24) = 4.64, p = .04, ηp2= .16, wherein the difference score (NT-NN) for P1 mean 
amplitude was more positive for the CT arm, (M = 2.86, SE = 1.09) than for the ABMT 
arm (M = -.95, SE = 1.18). At post-treatment, the CT arm had higher P1 mean amplitudes 
for NT stimuli than for NN stimuli, while the ABMT arm had lower P1 mean amplitudes 
for NT stimuli than for NN stimuli.  See Figure 5. 
Site Oz. A nonsignificant main effect of arm was found F(1,24) = .95, p = .34, 
ηp2= .04.  
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N170. 
Site POz. A nonsignificant main effect of arm was found F(1,24) = 2.75, p = .11, 
ηp2= .10. 
Site Oz. A nonsignificant main effect of arm was found F(1,24) = .89, p = .35, 
ηp2= .04.  
P2.  
Site POz. A nonsignificant main effect of arm was found F(1,24) = 1.29, p = .27, 
ηp2= .05. 
Site Oz. A nonsignificant main effect of arm was found F(1,24) = .31, p = .59, 
ηp2= .01.  
P3.  
Site POz. A nonsignificant main effect of arm was found F(1,24) = 2.92, p = .10, 
ηp2= .11  
Site Oz. A nonsignificant main effect of arm was found F(1,24) = 1.18, p = .29, 
ηp2= .05.  
Influence of ABMT on ERP Measures at Eight-week Follow-up. 
P1.  
Site POz. A nonsignificant main effect of arm was found F(1,23) = .60, p = .45, 
ηp2= .03. 
Site Oz. A nonsignificant main effect of arm was found F(1,23) = 1.12, p = .30, 
ηp2= .05.  
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N170. 
Site POz. A nonsignificant main effect of arm was found F(1,23) = 1.42, p = .25, 
ηp2= .06. 
Site Oz. A nonsignificant main effect of arm was found F(1,23) = 1.28, p = .27, 
ηp2= .05.  
P2. 
Site POz. A nonsignificant main effect of arm was found F(1,23) = 1.43, p = .24, 
ηp2= .06. 
Site Oz. A nonsignificant main effect of arm was found F(1,23) = .70, p = .41, 
ηp2= .03.  
P3.  
Site POz. A nonsignificant main effect of arm was found F(1,23) = 2.17, p = .15, 
ηp2= .09. 
Site Oz. A significant main effect of arm was found, F(1,23) = 4.92, p = .04, ηp2= 
.18, wherein the difference score (NT-NN) for P3 mean amplitude was more positive for 
the CT arm, (M = 3.73, SE = 1.76) than for the ABMT arm (M =-2.67, SE = 1.91). At 
eight-week follow-up, the CT arm had higher P3 mean amplitudes for NT stimuli than for 
NN stimuli (i.e., a positive difference score of NT-NN), while the ABMT arm had lower 
P3 mean amplitudes for NT stimuli than for NN stimuli. See Figure 6. 
Comparison of Part I and Part II Findings  
Regarding Hypothesis 1, in Part I, mean amplitudes of all components were not 
significantly correlated with attention bias or anxiety symptom measures, but in Part II, 
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when utilizing difference scores, attention bias score and youth self-rated anxiety were 
correlated significantly with the P2 component.  
Regarding Hypotheses 2 and 3, results in Part I and Part II were similar for post-
treatment, and Part II also revealed a treatment maintenance effect (at eight-week follow-
up). For P1 amplitude, Part I analyses revealed significantly higher amplitudes in the 
ABMT arm than in the CT arm within NN trials at post-treatment; Part II analyses 
revealed a similar pattern but showed attentional differences based on stimulus type; the 
CT arm showed higher amplitudes for NT than for NN trials, and the reverse pattern was 
found in the ABMT arm (i.e., higher amplitudes for NN than for NT). For N170, Part I 
analyses showed stronger N170 for NN trials than for NT trials within the CT arm; in 
contrast, Part II analyses revealed no significant between-arm differences in mean 
amplitude difference scores at post-treatment or at eight-week follow-up. P2 results 
across Parts I and II were comparable to those for N170, in which there was a weak 
interaction effect between stimulus type and arm in Part I analyses, but Part II analyses 
revealed no significant differences in stimulus difference scores at post-treatment or at 
eight-week follow-up. For P1, N170 and P2, all significant effects reported were at site 
POz, across Parts I and II. For P3, however, Part I analyses revealed the ABMT group 
showed higher amplitudes during NN trials than during NT trials at post-treatment at 
POz, whereas in Part II, analyses showed the reverse: NT-NN difference scores were 
positive in the CT arm and negative in the ABMT arm. However, this pattern in Part II 
was found at eight-week follow-up, not post-treatment, and at site Oz, not POz. Given the 
significant effects of site found in initial analyses, these discrepant findings for P3 
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suggest the effects found are distinct, and future studies should consider treatment effects 
as a function of site. 
Discussion 
 The current study examined the influence of a bottom-up, implicit training 
regimen, ABMT, on neural markers of attention to threat in youth anxiety CBT 
nonresponders. At post-treatment, I found that ABMT led to enhanced neural reactivity 
(i.e., larger amplitudes) in early-stage (P1) and late stage (P3) markers of attention in 
response to neutral stimuli. Using NT-NN difference scores, a proxy for differential 
attention across emotional valence in facial stimuli, I also found that ABMT led to 
relatively less allocation of neural resources towards threat stimuli than neutral stimuli in 
an early stage neural marker (P1), whereas the CT arm led to relatively greater allocation 
of neural resources towards threat stimuli than neutral stimuli in the same early stage 
neural marker (P1). These findings suggest early attentional orienting (i.e., P1) may shift 
as a result of ABMT, such that before treatment, youth with anxiety disorders allocate 
more early stage neural resources to processing threat stimuli, but after treatment, allocate 
more early stage neural resources to processing neutral stimuli.  
 This pattern of findings is consistent with the theoretical model underlying 
ABMT, in that repetitive implicit training leads to a shift in attentional resources away 
from threatening stimuli and towards neutral stimuli. Further, it provides evidence that 
this shift happens early in the stream of attentional processing (P1). This highlights the 
plasticity of early attentional processing, such as attentional orientation, to emotional 
stimuli in response to training, and suggests that the ABMT regimen specifically 
influences this early stage of processing instead of later stages of processing. Intriguingly, 
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another recent study reported that a single session of either a gamified ABMT protocol or 
a control task led to enhanced early stage (P1) markers of attention in response to 
threatening stimuli (Dennis-Tiwary et al., 2016). That finding similarly highlights the 
plasticity of early attentional processing in response to training but differs from the 
current finding in that enhancement effects were seen in processing of threatening stimuli 
instead of neutral stimuli. The difference in findings between Dennis-Tiwary et al. and 
the current study may be due to differences in the training regimen protocols, including 
format and number of sessions (one versus eight), and/or to differences in the ages and 
anxiety severity levels of the samples. 
 In the current study, at posttreatment, youth in the ABMT arm showed an ERP 
profile during early attention processing similar to a profile that was found in typically 
developing youth (i.e., larger P1 amplitudes in response to neutral stimuli; Bechor et al., 
unpublished manuscript). This similar profile suggests that ABMT may lead to a 
“normalization” of early stage attentional processing in youth with anxiety disorders by 
immediate posttreatment. Based on this finding, I speculate ABMT may enhance the 
allocation of early stage attentional resources towards emotionally ambiguous stimuli 
(i.e., neutral stimuli) in the service of more accurate identification of emotional valence.   
 At an eight-week follow-up evaluation, I found that youth participants in both 
study arms displayed significantly greater allocation of neural resources to early-stage 
processing of neutral facial stimuli (i.e., more negative N170 amplitudes), relative to 
pretreatment. Using NT-NN difference scores, a proxy for differential attention across 
emotional valence in facial stimuli, I found that youth participants in the CT arm 
displayed significantly greater allocation of neural resources to late-stage processing (i.e., 
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P3) of threatening stimuli than neutral stimuli, whereas youth participants in the ABMT 
arm displayed significantly greater allocation of neural resources to late-stage processing 
(i.e., P3) of neutral stimuli than threatening stimuli. Enhanced P3 has been linked to 
greater stimulus evaluation and response selection (M. Falkenstein et al., 1994; Verleger, 
1997). The current findings indicate that ABMT may selectively lead to greater later 
stage evaluation of emotionally ambiguous stimuli eight weeks after treatment ends. 
Overall, these findings at eight-week-follow-up suggest both forms of attention training 
lead to enhanced early stage neural processing (N170) of neutral stimuli in the weeks 
following treatment, while the ABMT task specifically leads to enhanced late stage 
neural processing (P3) of neutral stimuli in the weeks following treatment. 
 Consistent with a growing body of research, the current study overall did not find 
statistically significant associations between a behavioral reaction time measure of 
attention bias toward threat and ERP components or anxiety symptom severity, with one 
exception. The one exception was that the scores on behavioral reaction time measure 
were significantly correlated with the P2 amplitude on an NT-NN difference score, but 
the direction of the correlation was unexpected. Overall, these findings add to a literature 
indicating that behavioral reaction time measures may not provide sensitive or reliable 
measures of attentional processing (Brown et al., 2014; Kappenman, Farrens, Luck, & 
Proudfit, 2014a; Staugaard, 2009; Waechter, Nelson, Wright, Hyatt, & Oakman, 2014; 
Waechter & Stolz, 2015). 
Current findings should be evaluated in light of the study’s limitations. One 
limitation was relatively small sample size, which limited statistical power and prevented 
me from examining possible individual differences in ERP amplitudes as a function of 
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age, sex, anxiety severity or diagnostic category. Further, pre-treatment differences in 
ADHD diagnosis across arms posed difficulty in drawing conclusions about the effects of 
treatment. Reducing stimulus effects to a singular measure via the use of the NT-NN 
difference scores simplified analyses and reduced main effects of arm assignment at pre-
treatment; however, difference scores present challenges for interpretation of treatment 
effects (i.e., if both NT and NN amplitudes increased or decreased over time, their 
relative difference score may not have shown statistical change).  
 In spite of these limitations, the current findings identified possible neural 
markers of ABMT’s influence on attentional processes in youth with anxiety disorders. 
The findings further suggest that ABMT may lead to a normalization of attentional 
processing at post-treatment, such that youth with anxiety disorders who receive ABMT 
show an early stage ERP profile that is similar to typically developing youth and 
characterized by relatively greater neural processing of emotionally ambiguous stimuli 
than threatening stimuli. Future studies are encouraged to replicate the current findings in 
larger and diverse samples. Future studies should also include waitlist control arms to 
evaluate more stringently the training effects of the CT task, especially in light of the 
results found for facial stimuli processing.  
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Table 1. Diagnostic Information, Age, Behavioral Questionnaire and Dot Probe task 
scores. CT = Control Task arm, ABMT = treatment arm, M = mean, SD = standard 
deviation, RT = reaction time, 8WFU = Eight-week Follow-up, ADIS-C/P = Anxiety 
Disorders Interview Schedule, Child & Parent versions, PARS = Pediatric Anxiety 
Rating Scale, SCARED-P&C = Screen for Child Anxiety Related & Emotional 
Disorders, Parent & Child versions, NT = Neutral-Threat, N = Neutral-Neutral.  *denotes 
statistical significance (α =.05).  
 CT ABMT     
N 16 14     
ADIS-C/P Primary 
Diagnosis 
      
 Generalized 
Anxiety Disorder 
6 5     
 Social Phobia 5 8     
 Separation 
Anxiety Disorder 
2 1     
 Specific Phobia 1      
 Panic Disorder 1      
 Obsessive-
Compulsive 
Disorder 
1      
  M (SD) M (SD) t df p d 
Age 11.19 (2.86) 12.86 (2.77) -1.62 28 .12 .59 
PARS        
 Pre-treatment 17.00 (5.02) 18.77 (4.34) -1.00 27 .33 .38 
 Post-treatment 11.75 (6.54) 10.85 (7.73) .341 27 .74 .13 
 8WFU 9.14 (6.07) 12.10 (5.90) -1.19 22 .25 .49 
SCARED-P        
 Pre-treatment 25.69 (10.29) 33.93 (14.65) -1.80 28 .08 .65 
 Post-treatment 22.40 (12.75) 28.00 (15.05) -1.05 25 .31 .40 
 8WFU 17.53 (12.74) 26.80 (15.50) -1.25 23 .22 .65 
SCARED-C        
 Pre-treatment 25.44 (17.38) 25.14 (9.16) .06 23.33 .95 .02 
 Post-treatment 16.60 (16.35) 16.08 (11.87) .09 25 .93 .04 
 8WFU 17.53 (12.74) 20.81 (11.85) -.67 24 .51 .27 
Dot Probe Threat 
Bias Score  
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 Pre-treatment -.48 (15.58) .89 (15.20) -.24 28 .81 .09 
 Post-treatment 8.17 (28.68) 4.36 (14.82) .45 28 .66 .17 
 8WFU -6.65 (20.48) -2.78 (7.75) -.68 18.42 .51 .25 
Dot Probe Accuracy 
(%)  
      
 Pre-treatment .97 (.02) .97 (.03) -.07 28 .95 .00 
 Post-treatment .91 (.14) .97 (.03) -1.67 16.37 .11 .10 
 8WFU .95 (.06) .96 (.05) -.21 26 .83 .18 
Dot Probe RT (ms)        
 Pre-treatment 584.88 
(119.99) 
547.43 
(81.20) 
1.01 26.45 .32 .37 
 Post-treatment 560.13 
(83.97) 
506.07 
(84.33) 
1.76 28 .09 .64 
 8WFU 568.73 
(108.52) 
506.46 
(77.92) 
1.72 26 .10 .66 
Number of Trials 
(NT+NN) 
      
 Pre-treatment 148.44 
(57.40) 
173.57 
(25.52) 
-1.58 21.29 .13 .57 
 Post-treatment 145.81 
(53.31) 
181.79 
(26.35) 
-2.39 22.52 .03* .86 
 8WFU 148.19 
(52.85) 
189.71 
(21.94) 
-2.87 20.57 .01* 1.03 
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Table 2. Correlations between ERP Components and Behavioral Measures. Part I, Hypothesis 1: correlations between ERP 
components (P1, N170, P2 & P3) and anxiety symptoms (AB score, SCARED-C/P, PARS) at pre-treatment. AB = attention 
bias, PARS = Pediatric Anxiety Rating Scale, SCARED-P&C = Screen for Child Anxiety Related & Emotional Disorders, 
Parent & Child versions.  
 
Pre-treatment 
 
P1 N170 P2 P3 
POz 
 
Oz 
 
POz 
 
Oz 
 
POz 
 
Oz 
 
POz 
 
Oz 
 NT NN NT NN NT NN NT NN NT NN NT NN NT NN NT NN 
AB score .07 .08 .12 .18 .08 .10 .14 .25 -.06 -.04 .00 .15 .15 .08 .16 .25 
SCARED-P -.12 -.09 .02 .12 -.18 -.13 -.04 .07 -.16 -.13 -.06 -.01 -.12 -.12 -.14 -.04 
SCARED-C .12 -.12 .15 .07 .01 .02 .07 .08 .13 .11 .06 .07 .13 .10 .07 .03 
PARS  .02 .10 .17 .23 -.30 -.25 -.06 -.02 -.10 -.04 .02 .05 -.07 .04 .09 .18 
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Table 3. Main effects of stimulus type and arm at pre-treatment as calculated in a) Part I and b) main effects of arm in Part II.  
3a) Part I. 
     Site   POz Oz 
Component Main Effect F p η2 F p η2 
P1 Arm 2.49 .13 .09 4.27 .05* .15 
  Stimulus Type 5.61 .03* .18 1.29 .00** .29 
N170 Arm 1.71 .00** .30 1.67 .21 .06 
  Stimulus Type .09 .77 .00 12.78 .00** .34 
P2 Arm 6.21 .02* .20 9.85 .00** .28 
  Stimulus Type .77 .39 .03 1.57 .22 .06 
P3 Arm 3.22 .09 .11 4.35 .05* .15 
  Stimulus Type 1.05 .32 .04 2.64 .12 .10 
      
3b) Part II. 
     Site   POz Oz 
Component Main Effect F p η2 F p η2 
P1 Arm .46 .50 .02 1.09 .31 .04 
N170 Arm .06 .80 .00 .10 .75 .00 
P2 Arm .00 .95 .00 .09 .77 .00 
P3 Arm .69 .41 .03 .72 .40 .03 
*α < .05, **α < .01 
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Table 4. Part II, Hypothesis 1: correlations between ERP components (P1, N170, P2 & P3) and anxiety symptoms (AB score, 
SCARED-C/P, PARS) utilizing NT-NN difference scores at pre-treatment. AB = attention bias, PARS = Pediatric Anxiety 
Rating Scale, SCARED-P&C = Screen for Child Anxiety Related & Emotional Disorders, Parent & Child versions. 
Pre-treatment 
 
P1 N170 P2 P3 
POz Oz POz Oz POz Oz POz Oz 
AB score .01 -.13 -.04 -.28 -.07 -.369* .18 -.27 
SCARED-P -.09 -.26 -.17 -.29 -.08 -.10 -.03 -.28 
SCARED-C .354* .30 -.02 .00 .05 -.04 .10 .10 
PARS  -.10 -.09 -.17 -.12 -.16 -.07 -.29 -.27 
*α < .05, **α < .01 
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Figure 1. Waveforms across arms at POz. Component windows: P1 (100-160 ms), N170 (170-230 ms), P2 (230-280 ms), and 
P3 (300-380 ms). CT = Control Task arm, ABMT = Treatment arm. 
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Figure 2. Waveforms across arms at Oz. Component windows: P1 (100-160 ms), N170 (170-230 ms), P2 (230-280 ms), and P3 
(300-380 ms). CT = Control Task arm, ABMT = Treatment arm. 
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Figure 3. Post-hoc analyses for NT and NN waves across arms at post-treatment (Hypothesis 2) at POz. Figure 3(a) represents 
the a marginally significant main effect of arm on P1 mean amplitude during NN trials, F(1,24) = 3.14, p = .09, ηp2= .12; 
amplitudes in the ABMT arm (M = 8.39, SE = 1.49) were higher than in the CT arm (M = 4.39, SE = 1.37). Figure 3(b) shows 
the significant stimulus-type-by-arm interaction effect, F(1,23) = 4.53, p = .04, ηp2= .164 for P3 mean amplitudes at post-
treatment. Post-hoc analyses no significant main effects or arm or stimulus type.   There were no significant main or interaction 
effects at post-treatment Oz. CT = Control Task arm, ABMT = Treatment arm. *denotes significant effect, α = .05. 
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Figure 4. Post-hoc analyses for NT and NN waves across arms at eight-week follow-up (Hypothesis 3) at POz. Figure 4(a) 
represents the significant main effect of arm on P1 mean amplitude at eight-week follow-up, wherein P1 mean amplitude was 
significantly larger for the CT arm (M = 6.63, SE = 2.22) than for the ABMT arm, (M = -2.31, SE = 2.44).  Figure 4(b) 
represents the significant main effect of stimulus type within the CT arm, F(1,8) = 8.42, p = .02, ηp2= .51, wherein N170 mean 
amplitude at eight-week follow-up was significantly larger (more negative) during NN trials (M = 5.06, SE = 1.29) than during 
NT trials, (M = 7.49, SE = 2.35). There were no significant main or interaction effects at post-treatment at Oz. CT = Control 
Task arm, ABMT = Treatment arm. *denotes significant effect, α = .05.  
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Figure 5. POz differences scores (NT-NN) at pre-treatment, post-treatment and eight-week follow-up. A significant main effect 
of arm was found at POz at post-treatment, F(1,24) = 4.64, p = .04, ηp2= .16, wherein differential attention across stimulus type 
(NT-NN) for P1 mean amplitude was more positive for the CT arm, (M = 2.86, SE = 1.09) than for the ABMT arm (M =-.95, 
SE = 1.18). CT = Control Task arm, ABMT = Treatment arm. *denotes significant effect, α = .05. 
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Figure 6. Oz differences scores (NT-NN) at pre-treatment, post-treatment and eight-week follow-up. A significant main effect 
of arm was found, F(1,23) = 4.92, p = .04, ηp2= .18, wherein differential attention across stimulus type (NT-NN) for P3 mean 
amplitude was more positive for the CT arm, (M = 3.73, SE = 1.76) than for the ABMT arm (M =-2.67, SE = 1.91).  CT = 
Control Task arm, ABMT = Treatment arm. *denotes significant effect, α = .05.  
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Appendix 1. Measures 
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Children’s Depression Inventory 
 
KIDS SOMETIMES HAVE DIFFERENT FEELINGS AND IDEAS. 
 
THIS FORM LISTS THE FEELINGS AND IDEAS IN GROUPS. FROM EACH  
GROUP, PICK ONE SENTENCE THAT DESCRIBES YOU BEST FOR THE 
PAST TWO WEEKS. AFTER YOU PICK A SENTENCE FROM THE FIRST 
GROUP, GO ON TO THE NEXT GROUP. 
 
THERE IS NO RIGHT ANSWER OR WRONG ANSWER. JUST PICK THE 
SENTENCE THAT BEST DESCRIBES THE WAY YOU HAVE BEEN 
RECENTLY. PUT A MARK LIKE THIS  X  NEXT TO YOUR ANSWER. PUT 
THE MARK ON THE LINE NEXT TO THE SENTENCE THAT YOU PICK. 
 
HERE IS AN EXAMPLE OF HOW THIS FORM WORKS. TRY IT. PUT A 
MARK NEXT TO THE SENTENCE THAT DESCRIBES YOU BEST. 
 
EXAMPLE: 
_____ I READ BOOKS ALL THE TIME  
_____ I READ BOOKS ONCE IN A WHILE  
_____ I NEVER READ BOOKS 
 
REMEMBER, PICK OUT THE SENTENCES THAT DESCRIBE YOUR 
FEELINGS AND IDEAS IN THE PAST TWO WEEKS. 
 
 
1. _____ I AM SAD ONCE IN A WHILE 
_____ I AM SAD MANY TIMES 
_____ I AM SAD ALL THE TIME 
 
 
2. _____ NOTHING WILL EVER WORK OUT FOR ME  
_____ I AM NOT SURE IF THINGS WILL WORK OUT FOR ME 
_____ THINGS WILL WORK OUT FOR ME O.K. 
 
 
3. _____ I DO MOST THINGS O.K. 
_____ I DO MANY THINGS WRONG 
_____ I DO EVERYTHING WRONG 
 
 
4. _____ I HAVE FUN IN MANY THINGS 
_____ I HAVE FUN IN SOME THINGS 
_____ NOTHING IS FUN AT ALL 
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5. _____ I AM BAD ALL THE TIME 
_____ I AM BAD MANY TIMES 
_____ I AM BAD ONCE IN A WHILE 
 
 
6. _____ I THINK ABOUT BAD THINGS HAPPENING TO ME ONCE   
    IN A WHILE 
_____ I WORRY THAT BAD THINGS WILL HAPPEN TO ME 
_____ I AM SURE THAT TERRIBLE THINGS WILL HAPPEN TO ME 
 
 
7. _____ I HATE MYSELF 
_____ I DO NOT LIKE MYSELF 
_____ I LIKE MYSELF 
 
 
8. _____ ALL BAD THINGS ARE MY FAULT 
_____ MANY BAD THINGS ARE MY FAULT 
_____ BAD THINGS ARE NOT USUALLY MY FAULT 
 
 
9. _____ I DO NOT THINK ABOUT KILLING MYSELF 
_____ I THINK ABOUT KILLING MYSELF BUT I WOULD NOT   
    DO IT 
_____ I WANT TO KILL MYSELF 
 
 
10. _____ I FEEL LIKE CRYING EVERYDAY 
_____ I FEEL LIKE CRYING MANY DAYS 
_____ I FEEL LIKE CRYING ONCE IN A WHILE 
 
 
11. _____ THINGS BOTHER ME ALL THE TIME 
_____ THINGS BOTHER ME MANY TIMES 
_____ THINGS BOTHER ME ONCE IN A WHILE 
 
 
12. _____ I LIKE BEING WITH PEOPLE 
_____ I DO NOT LIKE BEING WITH PEOPLE MANY TIMES 
_____ I DO NOT WANT TO BE WITH PEOPLE AT ALL 
 
 
13. _____ I CANNOT MAKE UP MY MIND ABOUT THINGS 
_____ IT IS HARD TO MAKE UP MY MIND ABOUT THINGS 
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_____ I MAKE UP MY MIND ABOUT THINGS EASILY 
 
 
14. _____ I LOOK O.K. 
_____ THERE ARE SOME BAD THINGS ABOUT MY LOOKS 
_____ I LOOK UGLY 
 
 
15. _____ I HAVE TO PUSH MYSELF ALL THE TIME TO DO MY   
    SCHOOLWORK 
_____ I HAVE TO PUSH MYSELF MANY TIMES TO DO MY    
   SCHOOLWORK 
_____ DOING SCHOOLWORK IS NOT A BIG PROBLEM 
 
 
16. _____ I HAVE TROUBLE SLEEPING EVERY NIGHT 
_____ I HAVE TROUBLE SLEEPING MANY NIGHTS 
_____ I SLEEP PRETTY WELL 
 
 
17. _____ I AM TIRED ONCE IN A WHILE 
_____ I AM TIRED MANY DAYS 
_____ I AM TIRED ALL THE TIME 
 
 
18. _____ MOST DAYS I DO NOT FEEL LIKE EATING 
_____ MANY DAYS I DO NOT FEEL LIKE EATING 
_____ I EAT PRETTY WELL 
 
 
19. _____ I DO NOT WORRY ABOUT ACHES AND PAINS 
_____ I WORRY ABOUT ACHES AND PAINS MANY TIMES 
_____ I WORRY ABOUT ACHES AND PAINS ALL THE TIME 
 
 
20. _____ I DO NOT FEEL ALONE 
_____ I FEEL ALONE MANY TIMES 
_____ I FEEL ALONE ALL THE TIME 
 
 
21. _____ I NEVER HAVE FUN AT SCHOOL 
_____ I HAVE FUN AT SCHOOL ONLY ONCE IN A WHILE 
_____ I HAVE FUN AT SCHOOL MANY TIMES 
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22. _____ I HAVE PLENTY OF FRIENDS 
_____ I HAVE SOME FRIENDS BUT I WISH I HAD MORE 
_____ I DO NOT HAVE ANY FRIENDS 
 
 
23. _____ MY SCHOOLWORK IS ALRIGHT 
_____ MY SCHOOLWORK IS NOT AS GOOD AS BEFORE 
_____ I DO VERY BADLY IN SUBJECTS I USED TO BE GOOD IN 
 
 
24. _____ I CAN NEVER BE AS GOOD AS OTHER KIDS 
_____ I CAN BE AS GOOD AS OTHER KIDS IF I WANT TO 
_____ I AM JUST AS GOOD AS OTHER KIDS 
 
 
25. _____ NOBODY REALLY LOVES ME 
_____ I AM NOT SURE IF ANYBODY LOVES ME 
_____ I AM SURE THAT SOMEBODY LOVES ME 
 
 
26. _____ I USUALLY DO WHAT I AM TOLD 
_____ I DO NOT DO WHAT I AM TOLD MOST TIMES 
_____ I NEVER DO WHAT I AM TOLD 
 
 
27. _____ I GET ALONG WITH PEOPLE 
_____ I GET INTO FIGHTS MANY TIMES 
_____ I GET INTO FIGHTS ALL THE TIME 
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MASC 
This form is about how you might have been thinking, feeling, or acting recently. For 
each question, please check how often the statement is true for you. If the sentence is 
true about you a lot of the time, circle OFTEN. If it is true about you some of the time, 
circle SOMETIMES. If it is true about you once in a while, circle RARELY. If a 
sentence is hardly ever true about you, circle NEVER. Remember, there are no right or 
wrong answers, just answers about how you might have been feeling recently. 
Example:  
  Never 
true 
about 
me 
Rarely 
true 
about 
me 
Sometimes 
true about 
me 
Often 
true 
about 
me 
1. I’m scared of dogs. never rarely sometimes  often 
2. I don’t like thunderstorms. never rarely sometimes often 
 
  Never 
true 
about me 
Rarely 
true 
about 
me 
Sometimes 
true about 
me 
Often 
true 
about 
me 
1. I feel tense or uptight. never rarely sometimes often 
2. I usually ask permission. never rarely sometimes often 
3. I worry about other people laughing at 
me. 
never rarely sometimes often 
4. I get scared when my parents go away. never rarely sometimes often 
5. I have trouble getting my breath. never rarely sometimes often 
6. I keep my eyes open for danger. never rarely sometimes often 
7. The idea of going away to camp scares 
me. 
never rarely sometimes often 
8. I get shaky or jittery. never rarely sometimes often 
9. I try hard to obey my parents and 
teachers. 
never rarely sometimes often 
10. I’m afraid that other kids will make fun 
of me. 
never rarely sometimes often 
11. I try to stay near my mom or dad. never rarely sometimes often 
12. I get dizzy or faint feelings. never rarely sometimes often 
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  Never 
true 
about me 
Rarely 
true 
about 
me 
Sometimes 
true about 
me 
Often 
true 
about 
me 
13. I check things out first. never rarely sometimes often 
14. I worry about getting called on in class. never rarely sometimes often 
15. I’m jumpy. never rarely sometimes often 
16. I’m afraid other people will think I’m 
stupid.  
never rarely sometimes often 
17. I keep the light on at night. never rarely sometimes often 
18. I have pains in my chest. never rarely sometimes often 
19. I avoid going to places without my 
family. 
never rarely sometimes often 
20. I feel strange, weird, or unreal. never rarely sometimes often 
21. I try to do things other people will like. never rarely sometimes often 
22. I worry about what other people think of 
me. 
never rarely sometimes often 
23. I avoid watching scary movies and TV 
shows. 
never rarely sometimes often 
24. My heart races or skips beats. never rarely sometimes often 
25. I stay away from things that upset me. never rarely sometimes often 
26. I sleep next to someone from my family. never rarely sometimes often 
27. I feel restless and on edge. never rarely sometimes often 
28. I try to do everything exactly right. never rarely sometimes often 
29. I worry about doing something stupid or 
embarrassing. 
never rarely sometimes often 
30. I get scared riding in the car or on the 
bus. 
never rarely sometimes often 
31. I feel sick to my stomach. never rarely sometimes often 
32. If I get upset or scared, I let someone 
know right away. 
never rarely sometimes often 
33. I get nervous if I have to perform in 
public. 
never rarely sometimes often 
34. Bad weather, the dark, heights, animals, 
or bugs scare me. 
        
never 
         
rarely 
       
sometimes 
        
often 
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  Never 
true 
about me 
Rarely 
true 
about 
me 
Sometimes 
true about 
me 
Often 
true 
about 
me 
35. My hands shake. never rarely sometimes often 
36. I check to make sure things are safe. never rarely sometimes often 
37. I have trouble asking other kids to play 
with me. 
never rarely sometimes often 
38. My hands feel sweaty or cold. never rarely sometimes often 
39. I feel shy. never rarely sometimes often 
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RCMAS-Child 
 
Instructions: Read each question carefully. Put a circle around the word YES if you think 
it is true about you. Put a circle around the word NO if you think it is not true about you. 
 
 1. I have trouble making up my mind. yes no 
    
 2. I get nervous when things do not go the right way. yes no 
    
 3. Others seem to do things easier than I can. yes no 
    
 4. I like everyone I know. yes No 
 
 5. Often I have trouble getting my breath. yes No 
 
 6. I worry a lot of the time. yes no 
    
 7. I am afraid of a lot of things. yes no 
    
 8.  I am always kind. yes no 
    
 9. I get mad easily. yes no 
    
10. I worry about what my parents will say to me. yes no 
    
11. I feel that others do not like the way I do things. yes no 
    
12. I always have good manners. yes no 
    
13. It is hard for me to get to sleep at night. yes no 
    
14. I worry about what other people think about me. yes no 
    
15. I feel alone even when there are people with me. yes no 
    
16. I am always good. yes no 
    
17. Often I feel sick in my stomach. yes no 
    
18. My feelings get hurt easily. yes no 
    
19. My hands feel sweaty. yes no 
    
20. I am always nice to everyone. yes no 
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21. I am tired a lot. yes no 
    
22. I worry about what is going to happen. yes no 
    
23. Other children are happier than I. yes no 
    
24. I tell the truth every single time. yes no 
    
25. I have bad dreams. yes no 
    
26. My feelings get hurt easily when I am fussed at. yes no 
    
27. I feel someone will tell me I do things the wrong way. yes no 
    
28. I never get angry. yes no 
    
29. I wake up scared some of the time. yes no 
    
30. I worry when I go to bed at night. yes no 
    
31. It is hard for me to keep my mind on my schoolwork. yes no 
    
32. I never say things I shouldn’t. yes no 
    
33. I wiggle in my seat a lot. yes no 
    
34. I am nervous. yes no 
    
35. A lot of people are against me. yes no 
    
36. I never lie. yes no 
    
37. I often worry about something bad happening to me. yes no 
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RCMAS-Parent 
 
Instructions: Read each question carefully. Put a circle around the word YES if you think 
it is true about your child. Put a circle around the word NO if you think it is not true 
about your child. 
 
 1. My child has trouble making up his/her mind. yes no 
    
 2. My child gets nervous when things do not go the right way. yes No 
 
 3. Others seem to do things easier than my child can. yes no 
    
 4. My child likes everyone he/she knows. yes no 
    
 5. Often my child has trouble getting his/her breath. yes no 
    
 6. My child worries a lot of the time. yes no 
    
 7. My child is afraid of a lot of things. yes no 
    
 8.  My child is always kind. yes no 
    
 9. My child gets mad easily. yes no 
    
10. My child worries about what I will say to him/her. yes no 
    
11. My child feels that others do not like the way he/she does things. yes no 
    
12. My child always has good manners. yes no 
    
13. It is hard for my child to get to sleep at night. yes no 
    
14. My child worries about what other people think about him/her. yes no 
    
15. My child feels alone even when there are people with him/her. yes no 
    
16. My child is always good. yes no 
    
17. Often my child feels sick in his/her stomach. yes no 
    
18. My child’s feelings get hurt easily. yes no 
    
19. My child’s hands feel sweaty. yes no 
    
20. My child is always nice to everyone. yes no 
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21. My child is tired a lot. yes no 
    
22. My child worries about what is going to happen. yes no 
    
23. Other children are happier than my child. yes no 
    
24. My child tells the truth every single time. yes no 
    
25. My child has bad dreams. yes no 
    
26. My child’s feelings get hurt easily when he/she is fussed at. yes no 
    
27. My child feels someone will tell him/her that he/she does things the 
wrong way. 
yes no 
    
28. My child never gets angry. yes no 
    
29. My child wakes up scared some of the time. yes no 
    
30. My child worries when he/she goes to bed at night. yes no 
    
31. It is hard for my child to keep his/her mind on his/her schoolwork. yes no 
    
32. My child never says things he/she shouldn’t. yes no 
    
33. My child wiggles in his/her seat a lot. yes no 
    
34. My child is nervous. yes no 
    
35. A lot of people are against my child. yes no 
    
36. My child never lies. yes no 
    
37. My child often worries about something bad happening to him/her. yes no 
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Screen for Child Anxiety Related Disorders (SCARED) 
Child Version—Pg. 1 of 2 (To be filled out by the CHILD) 
 
Name:  ___________________________________ 
Date:    ___________________________________ 
 
Directions: 
Below is a list of sentences that describe how people feel. Read each phrase and decide if it is “Not True or 
Hardly Ever True” or “Somewhat True or Sometimes True” or “Very True or Often True” for you. Then for each 
sentence, fill in one circle that corresponds to the response that seems to describe you for the last 3 months.  
 
 0 
 
Not True or  
Hardly  
Ever True 
1 
 
Somewhat  
True or  
Sometimes 
True 
 
2 
 
Very True  
or Often  
True 
1. When I feel frightened, it is hard to breathe.    
2. I get headaches when I am at school.    
3. I don’t like to be with people I don’t know well.    
4. I get scared if I sleep away from home.    
5. I worry about other people liking me.    
6. When I get frightened, I feel like passing out.    
7. I am nervous.    
8. I follow my mother or father wherever they go.    
9. People tell me that I look nervous.    
10. I feel nervous with people I don’t know well.    
11. I get stomachaches at school.    
12. When I get frightened, I feel like I am going crazy.    
13. I worry about sleeping alone.    
14. I worry about being as good as other kids.    
15. When I get frightened, I feel like things are not real.    
16. I have nightmares about something bad happening to my 
parents. 
   
17. I worry about going to school.    
18. When I get frightened, my heart beats fast.    
19. I get shaky.    
20. I have nightmares about something bad happening to me.    
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SCORING: 
A total score of ≥ 25 may indicate the presence of an Anxiety Disorder. Scores higher that 30 are more specific. 
A score of 7 for items 1, 6, 9, 12, 15, 18, 19, 22, 24, 27, 30, 34, 38 may indicate Panic Disorder or Significant Somatic Symptoms. 
A score of 9 for items 5, 7, 14, 21, 23, 28, 33, 35, 37 may indicate Generalized Anxiety Disorder. 
A score of 5 for items 4, 8, 13, 16, 20, 25, 29, 31 may indicate Separation Anxiety Disorder. 
A score of 8 for items 3, 10, 26, 32, 39, 40, 41 may indicate Social Anxiety Disorder. 
A score of 3 for items 2, 11, 17, 36 may indicate Significant School Avoidance. 
Screen for Child Anxiety Related Disorders (SCARED) 
Child Version—Pg. 2 of 2 (To be filled out by the CHILD) 
 
 0 
 
Not True 
or  
Hardly  
Ever True 
1 
 
Somewhat  
True or  
Sometimes 
True 
 
2 
 
Very True  
or Often  
True 
21. I worry about things working out for me.    
22. When I get frightened, I sweat a lot.    
23. I am a worrier.    
24. I get really frightened for no reason at all.     
25. I am afraid to be alone in the house.    
26. It is hard for me to talk with people I don’t know well.     
27. When I get frightened, I feel like I am choking.    
28. People tell me that I worry too much.    
29. I don’t like to be away from my family.    
30. I am afraid of having anxiety (or panic) attacks.    
31. I worry that something bad might happen to my parents.    
32. I feel shy with people I don’t know well.     
33. I worry about what is going to happen in the future.    
34. When I get frightened, I feel like throwing up.    
35. I worry about how well I do things.    
36. I am scared to go to school.    
37. I worry about things that have already happened.    
38. When I get frightened, I feel dizzy.    
39. I feel nervous when I am with other children or adults and I  
 have to do something while they watch me (for example: read 
 aloud, speak, play a game, play a sport.) 
   
40. I feel nervous when I am going to parties, dances, or any 
place 
   
41. I am shy.    
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*For children ages 8 to 11, it is recommended that the clinician explain all questions, or have the child answer the  
questionnaire sitting with an adult in case they have any questions. 
 
Developed by Boris Birmaher, M.D., Suneeta Khetarpal, M.D., Marlane Cully, M.Ed., David Brent M.D., and Sandra McKenzie, Ph.D., 
Western 
Psychiatric Institute and Clinic, University of Pgh. (10/95). E-mail: birmaherb@msx.upmc.edu  
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Screen for Child Anxiety Related Disorders (SCARED) 
Parent Version—Pg. 1 of 2 (To be filled out by the PARENT) 
 
Name:  ___________________________________ 
Date:    ___________________________________ 
 
Directions: 
Below is a list of sentences that describe how people feel. Read each phrase and decide if it is “Not True or 
Hardly Ever True” or “Somewhat True or Sometimes True” or “Very True or Often True” for you. Then for each 
sentence, fill in one circle that corresponds to the response that seems to describe you for the last 3 months.  
 
 0 
 
Not True 
or  
Hardly  
Ever True 
1 
 
Somewhat  
True or  
Sometimes 
True 
 
2 
 
Very True  
or Often  
True 
1. When my child feels frightened, it is hard for him/her to 
breathe. 
   
2. My child gets headaches when he/she is at school.    
3. My child doesn’t like to be with people he/she doesn’t know 
well. 
   
4. My child gets scared if he/she sleeps away from home.    
5. My child worries about other people liking him/her.    
6. When my child gets frightened, he/she feels like passing out.    
7. My child is nervous.    
8. My child follows me wherever I go.    
9. People tell me that my child looks nervous.    
10. My child feels nervous with people he/she doesn’t know well.    
11. My child gets stomachaches at school.    
12. When my child gets frightened, he/she feels like he/she is 
going crazy. 
   
13. My child worries about sleeping alone.    
14. My child worries about being as good as other kids.    
15. When he/she gets frightened, he/she feels like things are not 
real 
   
16. My child has nightmares about something bad happening to 
his/her parents. 
   
17. My child worries about going to school.    
18. When my child gets frightened, his/her heart beats fast.    
19. He/she gets shaky.    
20. My child has nightmares about something bad happening to 
him/her.  
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SCORING: 
A total score of ≥ 25 may indicate the presence of an Anxiety Disorder. Scores higher that 30 are more specific. 
A score of 7 for items 1, 6, 9, 12, 15, 18, 19, 22, 24, 27, 30, 34, 38 may indicate Panic Disorder or Significant Somatic Symptoms. 
A score of 9 for items 5, 7, 14, 21, 23, 28, 33, 35, 37 may indicate Generalized Anxiety Disorder. 
A score of 5 for items 4, 8, 13, 16, 20, 25, 29, 31 may indicate Separation Anxiety Disorder. 
A score of 8 for items 3, 10, 26, 32, 39, 40, 41 may indicate Social Anxiety Disorder. 
A score of 3 for items 2, 11, 17, 36 may indicate Significant School Avoidance. 
 
Screen for Child Anxiety Related Disorders (SCARED) 
Parent Version—Pg. 2 of 2 (To be filled out by the PARENT) 
 
 0 
 
Not True 
or  
Hardly  
Ever True 
1 
 
Somewhat  
True or  
Sometimes 
True 
 
2 
 
Very True  
or Often  
True 
21. My child worries about things working out for him/her.    
22. When my child gets frightened, he/she sweats a lot.    
23. My child is a worrier.    
24. My child gets really frightened for no reason at all.    
25. My child is afraid to be alone in the house.    
26. It is hard for my child to talk with people he/she doesn’t know well.     
27. When my child gets frightened, he/she feels like he/she is choking.    
28. People tell me that my child worries too much.    
29. My child doesn’t like to be away from his/her family.    
30. My child is afraid of having anxiety (or panic) attacks.    
31. My child worries that something bad might happen to his/her 
parents. 
   
32. My child feels shy with people he/she doesn’t know well.    
33. My child worries about what is going to happen in the future.    
34. When my child gets frightened, he/she feels like throwing up.    
35. My child worries about how well he/she does things.    
36. My child is scared to go to school.    
37. My child worries about things that have already happened.    
38. When my child gets frightened, he/she feels dizzy.    
39. My child feels nervous when he/she is with other children or 
adults and he/she has to do something while they watch him/her (for 
example: read aloud, speak, play a game, play a sport.) 
   
40. My child feels nervous when he/she is going to parties, dances,  
or any place where there will be people that he/she doesn’t know well.  
   
41. My child is shy. 
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Developed by Boris Birmaher, M.D., Suneeta Khetarpal, M.D., Marlane Cully, M.Ed., David Brent M.D., and 
Sandra McKenzie, Ph.D., Western Psychiatric Institute and Clinic, University of Pgh. (10/95). E-mail: 
birmaherb@msx.upmc.edu 
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PEDIATRIC ANXIETY RATING SCALE (PARS) 
 
SYMPTOM CHECKLIST 
Instructions: Fill in the blanks with “1” (yes), “2” (no), or “9” (other, e.g., unable or unwilling to 
answer) 
 
SOCIAL INTERACTIONS or PERFORMANCE SITUATIONS 
“During the past week, have you (has s/he) worried about or avoided social situations?  
Let me give you some examples (refer to list).”     
Parent  Child  Rater 
1. Has fear of and/or avoids participating in group activities. ______  ______  ______ 
2. Has fear of and/or avoids going to a party or social event. ______  ______  ______ 
3. Has fear of and/or avoids talking with a stranger.  ______  ______  ______ 
4. Has fear of and/or avoids talking on the phone.  ______  ______  ______ 
5. Reluctant or refuses to talk in front of a group.  ______  ______  ______ 
6. Reluctant or refuses to write in front of other people. ______  ______  ______ 
7. Reluctant or refuses to eat in public.   ______  ______  ______ 
8. Reluctant or refuses to use a public bathroom.  ______  ______  ______ 
9. Reluctant or refuses to change into gym clothes or bathing suit   
   with others present.     ______  ______  ______ 
 
SEPARATION 
“Some children worry about being away from their mother or father.  What about you 
(your child)? Let me give you examples.” 
 
10. Worry about harm happening to attachment figures. ______  ______  ______ 
11. Worry about harm befalling self, including the fear of dying.______ ______  ______ 
12. Distress when separation occurs or is anticipated.  ______  ______  ______ 
13. Fear or reluctance to be alone.    ______  ______  ______ 
14. Reluctance or refusal to go to school or elsewhere. ______  ______  ______ 
15. Complaints of physical symptoms when separation occurs or is anticipated.    
       ______  ______  ______ 
16. Reluctance or refusal to go to sleep alone.  ______  ______  ______ 
17. Reluctance or refusal to sleep away from home.  ______  ______  ______ 
18. Nightmares with a separation theme.   ______  ______  ______ 
19. Clings to parent, or follows parent around the house. ______  ______  ______ 
 
 
 134 
 
 
 
GENERALIZED 
“Some people worry about a lot of different things.  What about you (your child)?  
What about during the past week?  Let me give you some examples.”   
 
20. Excessive worry about everyday or real-life problems. ______  ______  ______ 
21. Restlessness or feeling keyed-up or on edge.  ______  ______  ______ 
22. Easily fatigued.     ______  ______  ______ 
23. Difficulty concentrating or mind going blank.  ______  ______  ______ 
24. Irritability.      ______  ______  ______ 
25. Muscle tension or nonspecific tension.   ______  ______  ______ 
26. Sleep disturbance, especially difficulty falling asleep. ______  ______  ______ 
27. Dread or fearful anticipation (nonspecific).  ______  ______  ______ 
 
 
 
SPECIFIC PHOBIA 
“Do you worry about or have fears of animals (e.g. dog), etc?” 
 
28. Animal: Specify ___________________________ ______  ______  ______ 
29. Natural environment:  
(e.g., heights, storms) Specify: ___________________ ______  ______  ______ 
30. Blood-injection-injury: Specify: _______________ ______  ______  ______ 
31. Situational  
(e.g., airplane, elevator): Specify: _______________ ______  ______  ______ 
 
ACUTE PHYSICAL SIGNS & SYMPTOMS 
“Sometimes children notice feelings or changes in their bodies when they are anxious 
or worried?  What about you?  Let me give examples.” 
 
32. Blushing.      ______  ______  ______ 
33. Feels paralyzed.     ______  ______  ______ 
34. Trembling or shaking.     ______  ______  ______ 
35. Feels dizzy, unsteady, lightheaded or going to pass out. ______  ______  ______ 
36. Palpitations or pounding heart.    ______  ______  ______ 
37. Difficult breathing.     ______  ______  ______ 
(sensation of shortness of breath, smothering or choking). ______  ______  ______ 
38. Chills or hot flashes.     ______  ______  ______ 
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39. Sweating.      ______  ______  ______ 
40. Feels sick to stomach, nausea or abdominal distress. ______  ______  ______ 
41. Recurrent urge to go to bathroom.   ______  ______  ______ 
42.Chest pain or discomfort.    ______  ______  ______ 
43. Paresthesias  
(numbness or tingling sensation in fingers, toes, or perioral region).______ ______  ______ 
44. Problems swallowing or eating.    ______  ______  ______ 
 
 
 
 
OTHER 
45. Crying spells when in anxiety-provoking situations. ______  ______  ______ 
46. Temper tantrums when in anxiety-provoking situations.  
______  ______  ______ 
47. Needs to flee certain anxiety-provoking situations. ______  ______  ______ 
48. Keeps distance from other people.   ______  ______  ______ 
49. Fear of losing control or going crazy.  ______  ______  ______ 
50. Derealization (feeling of unreality)  
or depersonalization (detached from oneself).  ______  ______  ______ 
 Other anxiety symptoms: Specify: ___________________________________ 
     Specify: ___________________________________ 
     Specify: ___________________________________ 
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SEVERITY ITEMS 
Instructions: For each item circle the number that best characterizes the patient during the past 
week. 
 
Overall Number of Anxiety Symptoms (Circle code for past week only)  Code 
Not applicable          8  
Does not know          9 
No symptoms          0 
1 symptom          1 
2-3 symptoms          2 
4-6 symptoms          3 
7-10 symptoms          4 
More than 10 symptoms        5 
 
 
Overall Frequency of Anxiety Symptoms 
Not applicable          8  
Does not know          9 
No symptoms          0 
1 or 2 days a week         1 
3 or 4 days a week         2 
5 or 6 days a week         3 
Daily            4 
  
Several hours every day         5 
 
Overall Severity of Anxiety Feelings 
Not applicable          8 
Does not know.          9  
None. No anxious symptoms.        0 
Minimal: Very transient discomfort. Not clinically significant.    1 
Mild: Transient discomfort that is mildly disturbing. Borderline clinical  
significance. Intermediate between 1and 3.      2 
Moderate: Clearly nervous when anticipating or confronting the anxiety-provoking  3 
situation(s). Often unable to overcome these feelings.  
These feelings impact on well-being. 
Severe: Very distressed when anxious or when anticipating or confronting     
the anxiety-provoking situation (s). Usually unable to overcome this feeling.  
Intermediate between 3 and 5.         4 
Extreme: Feels wretched when anticipating or confronting     5 
anxiety-provoking situation(s). Often or almost totally unable to overcome this fear.  
Very marked impact on well being. 
 
Overall Severity of Physical Symptoms of Anxiety 
Not applicable           8 
Does not know          9 
None. No physical symptoms of anxiety.      0 
Minimal: Very transient physical symptoms of anxiety. Symptoms are not,   1 
or are hardly noticeable by others. Not clinically significant. 
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Mild:  Few physical symptoms: no lasting impact.       
           2 
 Borderline clinical significance. Intermediate between 1and 3.  
Moderate: Persistent physical symptoms of anxiety, especially during exposure  3 
 to the feared situation(s). Symptoms are noticeable by others and significantly 
 interfere with his/her ability to function in the situation.   
Severe:  Marked physical symptoms of substantial clinical significance.      
Intermediate between 3 and 5.         4 
Extreme: Severe and persistent physical symptoms of anxiety, especially during   5 
exposure to the feared situations(s). Symptoms are very obvious to others  
and often result in inability to function in the situation.  
 
Overall Avoidance of Anxiety-Provoking Situations 
NOTE: Rate all avoidance here; include school, home, activities, etc. in rating 
 
Not applicable          8 
Does not know          9 
None. Does not avoid the anxiety-provoking situation(s).    0 
 
Minimal: Very occasionally avoids the anxiety-provoking situation(s).    1 
Avoided situation(s) is/are not critical to his/her well-being.  
Mild:  Avoids anxiety-provoking situation(s) some of the time      
           2 
but no important situation is consistently avoided. Borderline  
clinical significance. Intermediate between 1 and 3.  
Moderate: Avoid anxiety-provoking situation(s) frequently.     3 
At least one important situation is avoided. 
Severe: Avoids anxiety-provoking situation most of the time       
or more than one important situation is consistently avoided. 
 Intermediate between 3 and 5.        4 
Extreme: Avoids all or almost all anxiety-provoking situations.    5 
 
Interference with Family Relationships and/or Performance at Home 
Not applicable          8 
Does not know          9 
None. No interference.         0 
 
Minimal: Very transient interference. No impact on relationships    1 
with family members or performance (tasks, etc.) at home. 
Mild: Slight impact on relationships or performance outside of the home.  2 
Borderline clinical significance. Intermediate between 1 and 3.  
Moderate: Clear interference. Either performance of tasks at home or frequency   3 
or quality of interaction with family members is affected: he/she might  
withdraw from interaction, or might be avoided/rejected by family members,  
or might have many conflicts with them. 
Severe: Marked interference in relationships with family members and/or   4 
performance at home. Of substantial clinical significance. 
Intermediate between 3 and 5.  
Extreme: Totally or almost totally unable to maintain appropriate family relationship  5 
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and/or function at home. 
 
 
Interference with Peer and Adult Relationships &/or Performance Outside of Home. 
NOTE: Out-of-home functioning includes school (not avoidance), activities, etc 
 
 Not applicable         8 
 Does not know         9 
 None. No interference.        0 
 
Minimal: Very transient interference. No impact on relationships with peers   1 
or teachers or other adults outside of the home. No impact on functioning  
outside of home, e.g., attending and performing group activities. 
Mild: Slight impact on relationships or performance outside of the home.   2 
Borderline clinical significance. Intermediate between 1 and 3. 
Moderate: Clear interference. Either performance outside of the home or frequency 3 
or quality of peer or adult interactions is affected: he/she might withdraw  
from interaction, or might be avoided/rejected by peers or adults, or might 
have conflicts with them. 
Severe: Marked interference in relationship with peers or adults outside of home   4 
and/or performance outside of home. Of substantial clinical significance.  
Intermediate between 3 and 5.  
Extreme: Totally or almost totally unable to maintain appropriate peer or   5 
adult relationship and/or function outside of home.   
 
 
 
Scoring: 
 
Severity Item Score 
1. Overall number of anxiety symptoms  
2. Overall frequency of anxiety symptoms  
3. Overall severity of anxiety feelings  
4. Overall severity of physical symptoms of 
anxiety 
 
5. Overall avoidance of anxiety provoking 
situations 
 
6. Interference with family relationships and/or 
performance at home 
 
7. Interference with peer and adult relationships 
and/or performance outside of home 
 
TOTAL  
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TAU/NIMH Attention Bias Modification Treatment  
 
 
 Tel-Aviv University / National Institute of Mental Health Attention 
Bias Modification Treatment  
 
 Bias measurement and training: Protocol  
 
 Introduction 
Below, you can review the detailed methods, installation instructions, and general 
guidelines for running the TAU/NIMH ABMT attention bias measurement and training 
procedure. This comprehensive tutorial outlines the entire behavioral assessment 
process.  
 
 The dot-probe task  
 
 Overview  
The dot-probe task forms the basis for both threat bias assessment and attention bias 
modification. Threat-related attention bias should be measured before and after the 
ABMT or placebo protocol. In the current dot-probe discrimination task, pairs of face 
stimuli, one angry and one neutral, are presented one above the other on the computer 
screen, followed by a small visual probe appearing in the location vacated by one of the 
face pictures (see figure below). Participants are required to respond as quickly as 
possible to the probe without compromising accuracy.  
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Response latencies on the task provide a “snap-shot” of the distribution of the subject’s 
attention, with faster responses to probes presented in the attended relative to the 
unattended location. For example, attention bias toward threat is evident when 
participants are faster to respond to probes that replace angry faces rather than neutral 
faces. The reverse pattern indicates threat-related attentional avoidance.  
 
Care must be taken to standardize the implementation of both the dot-probe task and 
attention training. The task should be administered in a quiet room with the lights 
dimmed. A research assistant should be present to ensure the task is being carried out 
as planned. Neither the research assistant nor the participant should speak during task 
administration.  
 
Stimuli 
 
1. All displays are presented within a white rectangle (58mm wide by 94mm tall, when 
screen resolution is configured to 1280 x 768 pixels; see Setup and Installation 
section below) mounted on a black background. The white rectangle is positioned in 
the mid-top portion of the screen.  
2. The fixation display consists of a black cross presented in the center of the white 
rectangle.  
3. The face stimuli are photographs of 20 different individuals (10 male, 10 female) taken 
from the NimStim stimulus set (Tottenham, et al., 2009), except for one female taken 
from the Matsumoto and Ekman set (Matsumoto & Ekman, 1989). All faces were 
placed on a background as in the Matsumoto and Ekman set. Two different pictures 
of each individual, depicting angry and neutral expressions, were selected. The face 
display consists of pairs of angry-neutral or neutral-neutral faces of the same 
individual. The face photographs are presented with equal distance from the top and 
bottom of the fixation cross, with a distance of 14mm between them. The top 
photograph is positioned about 20mm from the top edge of the screen. Each face 
photograph subtends 45mm in width and 34mm in height.  
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4. The face pairs were randomly divided into two sets (A and B). Each participant should 
be tested for pre- and post-ABM bias with one set, and trained with the other. Set 
assignment should be counterbalanced within the ABM and placebo groups.  
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5. The target-probe display consists of an arrow head pointing either left or right (“<” or 
“>”). The target appears at the location previously occupied by one of the faces, with 
a small, random jitter around the center of the face.  
  
Procedure  
In each trial in the task, the participant is presented with the fixation cross (500ms), 
followed by the face pair display (500ms), followed by the target display (until response). 
Response is followed by an inter-trial interval (500ms) composed of only the white 
rectangle on the black background. Across trials, each expression will equally likely be 
on the top or bottom position, and the probe will equally likely be < or >.  
 
Threat bias measurement  
 
The pre- and post-ABM measurement protocol consists of 120 trials (80 angry-neutral 
and 40 neutral-neutral presentations). Angry-face location, probe location, probe type, 
and actor are fully counterbalanced in presentation. If the subject performs with less than 
70% accuracy on the first 10 trials, the program will display a warning and the 
experiment will be aborted. This warning provides an opportunity to re-brief the subject 
and initiate data collection again.  
 
ABM/Placebo training  
 
The ABM/Placebo protocol consists of 160 trials (120 angry-neutral and 40 neutral-
neutral presentations). In the placebo condition, angry-face location, probe location, and 
actor are fully counterbalanced in presentation. In the ABM condition, the target appears 
at the neutral-face location in all angry-neutral trials. Probe type (< or >) is not factorially 
counterbalanced but appears with equal probability for each of the following: angry-face 
location, probe location, or actor. A short break is delivered every 40 trials. If accuracy is 
kept above 70%, no indication is provided during the break. However, if accuracy falls 
below 70% in the preceding block, a warning will accompany the break slide, providing 
an opportunity for the experimenter to remind the subject not to compromise accuracy. 
The participant then continues training.   
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Setup and installation  
Technical Requirements 
• A computer running E-Prime 2.x, E-Run application (PST, Pennsylvania, USA; 
http://www.pstnet.com/eprime.cfm)  
• Optimal computer screen resolution: 1280 x 768 pixels (with this resolution, the 
white rectangle display should be 58mm wide and 94mm tall). We strongly 
recommend that screen resolution is configured to these values. Variation of 
±6mm in the white  
 
Package set-up 
• A computer running E-Prime 2.x, E-Run application  
• Download the file ABMT.zip  
• Unzip its contents into a folder. The contents should include:  
o Bias_measure: runs the bias measurement session (E-Run 2.0 Script 
File)  
o Bias_train: runs the bias training session (E-Run 2.0 Script File)  
o images: a folder containing 6 image files, and 2 nested folders (“A” and 
“B”) each containing 20 additional image files  
• Note: The Bias_measure and Bias_train programs are independent of each 
other, but both require the relative location of the images folder to remain 
unchanged  
  
 
Running the procedures 
Bias measurement 
• Double-click Bias_measure to run a bias measurement session  
• Session sequence:  
o A series of input dialog boxes will prompt the experimenter to enter:  
▪ Research site number (should be provided by the 
coordinator)  
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▪ Subject number (1-32767)  
▪ Session number (e.g., 1 = pre, 2 = post)  
▪ Stimuli set to use (A or B)  
▪ Summary of startup info  
TAU/NIMH Attention Bias Modification Treatment 
 
▪ Instructions slide (see Appendix for instructions text)  
▪ 120 trials (no breaks) - ~4 minutes  
▪ Goodbye message  
• Output: two output files bearing the subject and session numbers will be 
generated in the same folder following a complete run:  
o .edat file (output in E-Prime Edat format)  
o .txt file (text log file, generated even when experiment is aborted)  
• Note:  
o A session cannot be paused midway  
o Use Ctrl+Alt+Shift to abort the session only if absolutely necessary. The 
.edat file will not be created for the trials run before the abort command; 
use E-Recovery application to transform the text log file into .edat format  
 
Training 
 
▪ Double-click Bias_train to run a bias measurement session  
▪ Session sequence:  
o A series of input dialog boxes will prompt the experimenter to enter:  
▪ Research site number (provided by the coordinator)  
▪ Subject number (1-32767)  
▪ Session number (e.g., 1 = pre, 2 = post)  
▪ Stimuli set to use (A or B)  
▪ Training type (1-10): should be obtained from the non-blind 
experimenter responsible for the study (see Information for the 
Non-Blind Experimenter document)  
▪ Summary of startup info  
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o Instructions slide (see Appendix for instructions text)  
o 160 trials (~5-6 minutes)  
▪ Four blocks of 40 trials  
▪ Rest break following each block (duration ad lib; preferably less 
than 2 minutes). If performance accuracy in preceding blocks was 
below 70%, a  
TAU/NIMH Attention Bias Modification Treatment 
 
message informing of low accuracy will be displayed. This will 
provide an opportunity for the experimenter to remind the 
participant that although they are to respond as quickly as 
possible, accuracy should not be compromised. No break will be 
given following the last block.  
o Goodbye message 
▪ Output: two output files bearing the subject and session numbers will be 
generated in the same folder following a complete run:  
o .edat file (output in E-Prime Edat format)  
o .txt file (text log file, generated even when experiment is aborted)  
▪ Note:  
o A session cannot be paused midway  
o Use Ctrl+Alt+Shift to abort the session only if absolutely necessary. The 
.edat file will not be created for the trials run before the abort command; 
use E-Recovery application to transform the text log file into .edat format  
 
How many training sessions? 
ABMT studies have used anywhere between one and 12 sessions of training. It appears 
that 8 bi-weekly sessions produce good clinical results. Thus, we recommend this 
amount of training, if possible. However, it is up to each participating site to determine 
the value of this parameter. 
 
Data analysis 
Threat bias scores and other behavioral indices can be directly generated using the 
provided Data Analysis Tool, a MATLAB standalone utility. Download the utility and 
consult the Data Analysis Protocol to learn how to transform the output produced by the 
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Bias_measure and Bias_train procedures into threat bias scores. The Data Analysis 
Tool utility does not require an existing MATLAB license. 
 
Contact  
 Registration and technical support: yairlab@freud.tau.ac.il  
 General inquiries: Rany Abend / abend@tau.ac.il  
 TAU Director: Yair Bar-Haim / yair1@post.tau.ac.il  
 NIMH Director: Daniel Pine / daniel.pine@nih.gov  
 Genetics: Thalia Eley / thalia.eley@kcl.ac.uk  
TAU/NIMH Attention Bias Modification Treatment 
References  
 
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring 
clinical anxiety: Psychometric properties. Journal of Consulting and Clinical 
Psychology, 56, 893-897.  
Birmaher, B., Brent, D. A., Chiappetta, L., Bridge, J., Monga, S., & Baugher, M. (1999). 
Psychometric properties of the Screen for Child Anxiety Related Emotional 
Disorders (SCARED): A replication study. Journal of the American Academy of 
Child and Adolescent Psychiatry, 38(10), 1230-1236.  
Birmaher, B., Khetarpal, S., Brent, D., Cully, M., Balach, L., Kaufman, J., et al. (1997). 
The screen for child anxiety related emotional disorders (SCARED): Scale 
construction and psychometric characteristics. Journal of the American Academy 
of Child and Adolescent Psychiatry, 36(4), 545-553.  
Matsumoto, D., & Ekman, P. (1989). he Japanese and Caucasian facial expressions of 
emotion (JACFEE) and neutrals (JACNeuF). San Francisco State University, San 
Francisco.  
Tottenham, N., Tanaka, J., Leon, A., McCarry, T., Nurse, M., Hare, T., et al. (2009). The 
NimStim set of facial expressions: Judgments from untrained research 
participants. Psychiatry Research, 168, 242-249. 
  
 147 
 
 
TAU/NIMH Attention Bias Modification Treatment    Updated May 
2015 
 
Tel-Aviv University / National Institute of Mental Health Attention 
Bias Modification Treatment  
 
 ABMT Analysis Tool v2.0: Installing and Running  
 
 
Downloading TAU/NIMH ABMT Analysis Tool v2.0  
1. Download the MATLAB standalone utility installer (v7.9; file name: 
MCRInstaller_7.9.exe; 257MB) from http://people.socsci.tau.ac.il/mu/wp-
content/themes/yairbarhaimhome/MCRInstaller_7.9.exe  
a. Run the file.  
b. "Next" your way through the install process.  
c. If no error occurred throughout the process, the MATLAB standalone 
utility was installed properly.  
2. Download the TAU/NIMH ABMT analysis tool v2.0 (file name: 
TAU_ABMT_v2.0.exe; 166KB) to a folder of your choice, from 
http://people.socsci.tau.ac.il/mu/wp-
content/themes/yairbarhaimhome/TAU_ABMT_v2.0.exe. 
 
 
Preparing the input data file for analysis  
 
The analysis tool can read Excel 2003-07 (.xls) or 2010-13 (.xslx) files that were 
converted from a merged E-Prime file (.emrg2).  
How to merge the output files and convert the merged file to Excel format:  
1. Run E-Merge to merge all the experiment output files (.edat format) you wish to 
analyze as a group. If you ran several sessions, merge each session separately. 
The output is an .emrg2 file.  
2. Open the merged file using the E-Prime's E-DataAid.  
3. Export its contents to Excel format using the Export button. Note that the 
resulting file will actually be in text format (.txt).  
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4. Open the text file using Excel.  
5. Delete the first row (it should contain the name of the merged file), so that cell A1 
contains the string ExperimentName.  
TAU/NIMH Attention Bias Modification Treatment    Updated May 
2015 
 
6. Save the file in Excel format (.xls or .xlsx).  
  
Running the TAU/NIMH ABMT Analysis Tool  
 
1. Open the file analysis tool by double-clicking the file (TAU_ABMT_v2.0.exe).  
2. The tool should open in a small window. Allow up to about a minute for the tool to 
open. If it fails to open, restart the computer and try again. If that didn't help, 
contact us at abend@tau.ac.il, and we'll try to help.  
3. Click the Load button on the right. Browse and choose the Excel output file you 
want to analyze. It may take up to a minute for the file to load (depending on its 
size). When it is done loading, the file's name will appear in the field to the left of 
the Load button.  
4. Click the Analyze button to analyze the data and generate an output file. This file 
will be saved in the same folder as the input file, and its name will be the same 
as that of the input file, with the suffix "analyzed". A preview of the output will 
appear in the Output preview area.  
 
Reading the TAU/NIMH ABMT Analysis Tool v 2.0 output file 
 
1. Double-click the Excel output file. If a warning about a different format than 
specified by the file extension, click Yes.  
2. Sheet 1 contains the calculated attention bias scores of your data, and additional 
data.  
a. Column A: subject ID  
b. Column B: session number  
c. Column C: session date (may need to format cells for correct display)  
d. Column D: session date (may need to format cells for correct display)  
 149 
 
 
e. Columns F-J: mean accuracy data (for: all trials, neutral trials, threat 
trials, all NT trials, all NN trials)  
f. Columns K-O: mean RT data (for: all trials, neutral NT trials, threat NT 
trials, all NT trials, all NN trials)  
g. Column P: threat bias score (mean of neutral NT trials minus mean of 
threat NT trials)  
h. Additional columns may appear in case happy stimuli were used  
TAU/NIMH Attention Bias Modification Treatment    Updated May 
2015 
 
Reaction time cleanup specifications  
 
1. Trial RTs were cleaned up before being analyzed, using the following method:  
2. All trial RTs shorter than 150ms or longer than 2000ms or in which an incorrect 
was response was made were removed.  
3. Then, Z-scores were calculated per trial type (neutral-threat/neutral-
happy/neutral-neutral) and valence of face preceding the probe 
(threat/happy/neutral). Trials with Z-scores greater than |2.5| were removed.  
4. Analyses were conducted on the remaining trial RTs (generally about 94% of the 
original trials).  
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ABMT First Session (A1) 
 
1. Bring child and parent to  room 
2. Welcome 
a. Counselor thanks family for completing the most recent assessment 
b. Empathize that child is still experiencing anxiety 
i. “As you know when you came in for your last interview and spoke with 
[assessor], the two of you still had concerns regarding [child’s] anxiety. 
I’m sorry to hear that! [child] is still having difficulties, and I would like 
to speak to you both about this, but before I do, I would like to explain 
more about what we will be doing in the treatment.” 
c. Review purpose of ABMT/remind them they may be in the Placebo Group 
i. “When you come in, you [child] will be doing one of two types of 
computer tasks, and this task will be the same each time. I do not 
know which of the two kinds of computer tasks you will be doing, but I 
will be asking you which one you THINK you were doing at the end of 
the study. “ 
ii. “The computer task [child] MAY be doing here for the next four weeks 
is a type of new computer treatment that has been shown to help 
some children’s anxiety get better. It is equally likely you will be doing 
a similar task that may or may not help your anxiety get better. The 
important thing is that you complete all the treatments.” 
3. Remind parent and child of basic procedure 
a. Coming in twice a week for four weeks 
b. Every even-numbered session, child and parent will complete measures 
i. “This treatment is different from ones you may have heard of up until 
now. You’ll be coming in for two sessions a week for about 30 minutes 
each time. When you come in the first time that week, you’ll come in 
here and do the computer treatment task. When you come in the 
second time that week, you’ll complete the computer task AND some 
short questionnaires about your anxious feelings.” 
4. Have child leave room briefly 
5. Inquiry with parent about child’s anxiety  
a. Ask more about interference  
b. Ask what parent would like to change about interference 
c. Suggestion: “so when you were last interviewed, you said [child] 
[SYMPTOM]…How is that progressing?....Do you feel it is interfering? 
How?...What kind of changes would you like to see regarding this?” 
d. Clarify any questions/concerns with parent 
6. Have parent leave room briefly 
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7. Inquiry with child about anxiety diagnosis 
a. Ask more about interference 
b. As what child would like to change about interference 
c. Suggestion: “so when you were last interviewed, you said you 
[SYMPTOM]…How is that progressing?....Do you feel it is interfering? How? 
...What kind of changes would you like to see regarding this?” 
8. Clarify any questions/concerns with child 
9. Child completes Treatment 1 (A1)   for this, use completed Treatment A1 Prep Sheet 
10. Bring parent back to treatment room 
a. Explain that each treatment session may seem short, but research supports its 
effectiveness 
i. Emphasize attendance at EVERY session and completion in 4 WEEKS’ 
time 
ii. Treatment must be done with practice, as the child learned in CAPP 
iii. Suggestion: “[Child], what did you think of the task? Although this 
treatment is very brief, it has been shown to help young people with 
their anxiety. However, the treatment is not going to be effective right 
after the first session. It is more likely to be effective if you come twice a 
week, every week. ” 
b. Remind parent of agreed-upon treatment time/upcoming appointments 
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A2/Session 2 - Procedure 
 
1. Bring child to  room 
2. Remind child of procedure 
a. At every even-numbered session, child will complete measures  
3. Child completes Treatment 2 (A2)  for this, use completed Treatment A2 Prep Sheet 
4. Have child and parent complete packet A2 
a. Child A2 packet 
b. Parent A2 packet  
5. Remind parent of agreed-upon treatment time/upcoming appointments 
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B1/Session 3 - Procedure 
 
1. Bring child to  room 
2. Child completes Treatment 3 (B1)  for this, use completed Treatment B1 Prep Sheet 
3. Remind parent of agreed-upon treatment time/upcoming appointments 
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B2/Session 4 - Procedure 
 
1. Bring child to  room 
2. Child completes Treatment 4 (B2)  for this, use completed Treatment B2 Prep Sheet 
3. Have child and parent complete packet B2 
a. Child B2 packet 
b. Parent B2 packet  
4. Remind parent of agreed-upon treatment time/upcoming appointments 
5. **After this appointment, Counselor informs CCs about family’s needing POST 
assessment 
a. Assessment coordinator calls family and assigns counselor  
b. Assessment coordinator inquires about scheduling 2MO FU assessment with 
parent  
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C1/Session 5 - Procedure 
 
1. Bring child to  room 
2. Child completes Treatment 5 (C1)  for this, use completed Treatment C1 Prep Sheet 
3. Remind parent of agreed-upon treatment time/upcoming appointments 
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C2/Session 6 - Procedure 
 
1. Bring child to  room 
2. Child completes Treatment 6 (C2)  for this, use completed Treatment C2 Prep Sheet 
3. Have child and parent complete packet C2 
a. Child C2 packet 
b. Parent C2 packet  
4. Remind parent of agreed-upon treatment time/upcoming appointments 
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D1/Session 7 - Procedure 
1. Bring child to  room 
2. Child completes Treatment 7 (D1)  for this, use completed Treatment D1 Prep Sheet 
3. Remind parent of agreed-upon treatment time/upcoming appointments 
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D2/Session 8 - Procedure 
 
1. Bring child to  room 
2. Child completes Treatment 6 (C2)  
3. Have child and parent complete packet D2 
a. Child D2 packet 
b. Parent D2 packet  
4. Remind parent of agreed-upon treatment time/upcoming appointments 
a. Wrap up treatment 
i. Note progress of child symptoms/review 
ii. Remind family to abstain from outside treatments until 2MO FU 
assessment 
b. Remind parent of POST appointment 
c. Remind parent of 2MO FU appointment  
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APPENDICES 
 
Appendix A: Measurement/Treatment Task Instructions 
Appendix B: Group Placement Perception Form 
Appendix C: Prep Sheets: Assessment, Treatment, Re-Run 
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Appendix A: Measurement/Treatment Task Instructions 
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ABMT - Attention Bias Measurement Program: 
PRE/POST/2MO FU Assessments 
1. On the Desktop, find the ‘ABMT’ Folder. Double-click on: 
“Bias_measure_match_screen_res.ebs2” 
a. NOTES: Purple icon, E-Run 2.0 Script File; should be the 
first file 
2. If you get the message ‘The file chosen is not recognized by E-Run…” 
click OK 
3. Enter the following information: 
a. Research Site Number → 3 
b. Subject Number  
i. [Case ID] (example: 0000) OR 
ii. [ABMT Case ID without ‘A’] (ex: A000 → 
‘000’) 
c. Session Number  
i. If this is a PRE [ABMT] → [1] or [IA2] → [1.2] 
ii. If this is a POST→ [2] 
iii. If this is a 2MO Follow-Up [ABMT] → [4] 
d. Stimuli Set to Use (A or B)  
i. If the Case ID ends in an ODD number →A 
ii. If the Case ID ends in an EVEN number or ZERO →B 
4. Summary dialog box appears 
a. Confirm that all is correct 
5. Guide child through the instructions on the screen 
a. MAKE SURE the child uses dominant hand when clicking 
b. Encourage the child to go as fast as he/she can 
c. Stand by in case the child needs assistance 
i. Stay out of direct line of sight of child 
1. Minimize distractions/interruptions as much as 
possible 
6. IF NEEDED: abort the program by pressing CTRL + ALT +SHIFT 
7. The measurement file should save automatically to the ABMT Folder 
a. The file will be called “Bias_measure_match_screen_res-XXXX-X” 
(where XXXX is CAPP Case ID and X is the Session Number code) 
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ABMT and CAPP– Attention Bias Treatment Program 
 
1. On the Desktop, find the ‘ABMT’ Folder. Double-click on: 
“Bias_train_match_screen_res.ebs2” 
a. NOTES: Purple icon, E-Run 2.0 Script File; should be the 
first file 
2. If you get the message ‘The file chosen is not recognized by E-Run…” 
click OK 
3. Enter the following information: 
a. Research Site Number → 3 
b. Subject Number  
i. [Case ID without letters] (ex: A000 → 
‘000’) 
c. Session Number  
i. If this is Session A1→ [1] 
ii. If this is Session A2→ [2] 
iii. If this is Session B1→ [3] 
iv. If this is Session B2→ [4] 
v. If this is Session C1→ [5] 
vi. If this is Session C2→ [6] 
vii. If this is Session D1→ [7] 
viii. If this is Session D2→ [8] 
d. Stimuli Set to Use (A or B) – REVERSE COUNTERBALANCE 
i. If the Case ID ends in an ODD number →B 
ii. If the Case ID ends in an EVEN number or ZERO →A 
e. Training Type  
i. If the Subject is in CONDITION 1 →3 
ii. If the Subject is in CONDITION 2 →8 
4. Summary dialog box appears 
a. Confirm that all is correct 
5. Guide child through the instructions on the screen 
a. MAKE SURE the child uses dominant hand when clicking 
b. Encourage the child to go as fast as he/she can 
c. Stand by in case the child needs assistance 
i. Stay out of direct line of sight of child 
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1. Minimize distractions/interruptions as much as 
possible 
6. IF NEEDED: abort the program by pressing CTRL + ALT +SHIFT 
7. The treatment file should save automatically to the ABMT Folder 
a. The file will be called “Bias_train_match_screen_res-XXX-X” (where 
XXX is ABMT without A and X is the Session Number code) 
 
Troubleshooting ABMT Measurement/Treatment Tasks 
 
Problem: When opening the ABMT program for measurement, there are times that an error 
may occur pertaining to the screen resolution. The message states the following:  
 
The following runtime error occurred: Application-defined or object-defined error 
Line: 939 
Error Number: -999 
 
Solution:  
(1) Go to the start Menu on the bottom right of the Desktop and type “resolution” 
(2) Click “Adjust Screen Resolution”  
(3) Click “Advanced Settings”  
(4) Click on the second tab labeled “Monitor” 
(5) Open the drop down menu labeled “Screen refresh rate” and select 60 Hertz  
(6) Click Apply and reattempt the ABMT task 
(7) re-run task to confirm flicker rate has been changed  
 
Suggestion: Check this option when setting up the computer to make the process faster. 
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Appendix B: Group Placement Perception Form 
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Group Placement Perception Form 
 
Parent: 
 
Now that you and your child have completed the Eight-Week Follow-Up 
Assessment, in which condition do you think your child was placed? (circle) 
 
 
 
 
PLACEBO CONDITION   TREATMENT CONDITION 
   
 
 
 
 
 
 
Child: 
 
Now that you and your parent have completed the Eight-Week Follow-Up 
Assessment, in which condition do you think you were placed? (circle) 
 
 
 
 
PLACEBO CONDITION   TREATMENT CONDITION 
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Appendix C: Prep Sheets 
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ABMT RCT ASSESSMENT – PREP SHEET 
 
Last Name: ________________ 
Child First Name: _____________ 
Parent Last Name: ______________ 
 
Time Point (Circle):    PRE  POST  8W 
FU 
 
Research Site 
Number 
3 
Case ID  
Session 
Number 
 
Stimuli Set  
  
 
Next Appointment Date: _______________ 
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Notes: 
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
____________________________________ 
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ABMT TREATMENT SESSION – PREP 
SHEET 
 
Last Name: ________________ 
Child First Name: _____________ 
Parent Last Name: ______________ 
 
Research Site 
Number 
3 
Case ID  
Session 
Number 
 
Stimuli Set  
Training Type  
 
 
Next Appointment Date: _______________ 
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Notes: 
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
___________________________________________
____________________________________ 
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